% Options for packages loaded elsewhere
\PassOptionsToPackage{unicode}{hyperref}
\PassOptionsToPackage{hyphens}{url}
\PassOptionsToPackage{dvipsnames,svgnames,x11names}{xcolor}
%
\documentclass[
  super,
  preprint,
  3p]{elsarticle}

\usepackage{amsmath,amssymb}
\usepackage{setspace}
\usepackage{iftex}
\ifPDFTeX
  \usepackage[T1]{fontenc}
  \usepackage[utf8]{inputenc}
  \usepackage{textcomp} % provide euro and other symbols
\else % if luatex or xetex
  \usepackage{unicode-math}
  \defaultfontfeatures{Scale=MatchLowercase}
  \defaultfontfeatures[\rmfamily]{Ligatures=TeX,Scale=1}
\fi
\usepackage{lmodern}
\ifPDFTeX\else  
    % xetex/luatex font selection
  \setmainfont[]{Comic Sans MS}
\fi
% Use upquote if available, for straight quotes in verbatim environments
\IfFileExists{upquote.sty}{\usepackage{upquote}}{}
\IfFileExists{microtype.sty}{% use microtype if available
  \usepackage[]{microtype}
  \UseMicrotypeSet[protrusion]{basicmath} % disable protrusion for tt fonts
}{}
\makeatletter
\@ifundefined{KOMAClassName}{% if non-KOMA class
  \IfFileExists{parskip.sty}{%
    \usepackage{parskip}
  }{% else
    \setlength{\parindent}{0pt}
    \setlength{\parskip}{6pt plus 2pt minus 1pt}}
}{% if KOMA class
  \KOMAoptions{parskip=half}}
\makeatother
\usepackage{xcolor}
\usepackage{soul}
\setlength{\emergencystretch}{3em} % prevent overfull lines
\setcounter{secnumdepth}{5}
% Make \paragraph and \subparagraph free-standing
\ifx\paragraph\undefined\else
  \let\oldparagraph\paragraph
  \renewcommand{\paragraph}[1]{\oldparagraph{#1}\mbox{}}
\fi
\ifx\subparagraph\undefined\else
  \let\oldsubparagraph\subparagraph
  \renewcommand{\subparagraph}[1]{\oldsubparagraph{#1}\mbox{}}
\fi


\providecommand{\tightlist}{%
  \setlength{\itemsep}{0pt}\setlength{\parskip}{0pt}}\usepackage{longtable,booktabs,array}
\usepackage{calc} % for calculating minipage widths
% Correct order of tables after \paragraph or \subparagraph
\usepackage{etoolbox}
\makeatletter
\patchcmd\longtable{\par}{\if@noskipsec\mbox{}\fi\par}{}{}
\makeatother
% Allow footnotes in longtable head/foot
\IfFileExists{footnotehyper.sty}{\usepackage{footnotehyper}}{\usepackage{footnote}}
\makesavenoteenv{longtable}
\usepackage{graphicx}
\makeatletter
\def\maxwidth{\ifdim\Gin@nat@width>\linewidth\linewidth\else\Gin@nat@width\fi}
\def\maxheight{\ifdim\Gin@nat@height>\textheight\textheight\else\Gin@nat@height\fi}
\makeatother
% Scale images if necessary, so that they will not overflow the page
% margins by default, and it is still possible to overwrite the defaults
% using explicit options in \includegraphics[width, height, ...]{}
\setkeys{Gin}{width=\maxwidth,height=\maxheight,keepaspectratio}
% Set default figure placement to htbp
\makeatletter
\def\fps@figure{htbp}
\makeatother

\makeatletter
\makeatother
\makeatletter
\makeatother
\makeatletter
\@ifpackageloaded{caption}{}{\usepackage{caption}}
\AtBeginDocument{%
\ifdefined\contentsname
  \renewcommand*\contentsname{Table of contents}
\else
  \newcommand\contentsname{Table of contents}
\fi
\ifdefined\listfigurename
  \renewcommand*\listfigurename{List of Figures}
\else
  \newcommand\listfigurename{List of Figures}
\fi
\ifdefined\listtablename
  \renewcommand*\listtablename{List of Tables}
\else
  \newcommand\listtablename{List of Tables}
\fi
\ifdefined\figurename
  \renewcommand*\figurename{Figure}
\else
  \newcommand\figurename{Figure}
\fi
\ifdefined\tablename
  \renewcommand*\tablename{Table}
\else
  \newcommand\tablename{Table}
\fi
}
\@ifpackageloaded{float}{}{\usepackage{float}}
\floatstyle{ruled}
\@ifundefined{c@chapter}{\newfloat{codelisting}{h}{lop}}{\newfloat{codelisting}{h}{lop}[chapter]}
\floatname{codelisting}{Listing}
\newcommand*\listoflistings{\listof{codelisting}{List of Listings}}
\makeatother
\makeatletter
\@ifpackageloaded{caption}{}{\usepackage{caption}}
\@ifpackageloaded{subcaption}{}{\usepackage{subcaption}}
\makeatother
\makeatletter
\@ifpackageloaded{tcolorbox}{}{\usepackage[skins,breakable]{tcolorbox}}
\makeatother
\makeatletter
\@ifundefined{shadecolor}{\definecolor{shadecolor}{rgb}{.97, .97, .97}}
\makeatother
\makeatletter
\makeatother
\makeatletter
\makeatother
\journal{Reg Tox Pharmacol}
\ifLuaTeX
  \usepackage{selnolig}  % disable illegal ligatures
\fi
\usepackage[]{natbib}
\bibliographystyle{elsarticle-num}
\IfFileExists{bookmark.sty}{\usepackage{bookmark}}{\usepackage{hyperref}}
\IfFileExists{xurl.sty}{\usepackage{xurl}}{} % add URL line breaks if available
\urlstyle{same} % disable monospaced font for URLs
\hypersetup{
  pdftitle={Development of Chemical Categories for Per- and Polyfluoroalkyl substances (PFAS) to Faciliate the Selection of Potential Candidates for Tiered Toxicological Testing and Human Health Assessment},
  pdfauthor={Grace Patlewicz; Richard Judson; John Cowden; Antony Williams; Kelly Carstens; Sigmund Degitz; Stephanie Padilla; Katie Paul Friedman; John Wambaugh; Barbara Wetmore; Stan Barone; Jeff Dawson; Anna Lowitt; Tala Henry; Russell S Thomas},
  pdfkeywords={Per- and Polyfluoroalkyl substances (PFAS), Chemical
categories, read-across, New Approach Methods (NAMs), tiered
testing, Toxic Substances Control Act (TSCA)},
  colorlinks=true,
  linkcolor={blue},
  filecolor={Maroon},
  citecolor={Blue},
  urlcolor={Blue},
  pdfcreator={LaTeX via pandoc}}

\setlength{\parindent}{6pt}
\begin{document}

\begin{frontmatter}
\title{Development of Chemical Categories for Per- and Polyfluoroalkyl
substances (PFAS) to Faciliate the Selection of Potential Candidates for
Tiered Toxicological Testing and Human Health Assessment \\\large{PFAS
categories for tiered toxicity assessment} }
\author[1]{Grace Patlewicz%
\corref{cor1}%
}
 \ead{patlewicz.grace@epa.gov} 
\author[1]{Richard Judson%
%
}

\author[1]{John Cowden%
%
}

\author[1]{Antony Williams%
%
}

\author[1]{Kelly Carstens%
%
}

\author[1]{Sigmund Degitz%
%
}

\author[1]{Stephanie Padilla%
%
}

\author[1]{Katie Paul Friedman%
%
}

\author[1]{John Wambaugh%
%
}

\author[1]{Barbara Wetmore%
%
}

\author[2]{Stan Barone%
%
}

\author[2]{Jeff Dawson%
%
}

\author[2]{Anna Lowitt%
%
}

\author[2]{Tala Henry%
%
}

\author[1]{Russell S Thomas%
%
}


\affiliation[1]{organization={Center for Computational Toxicology and
Exposure (CCTE), US Environmental Protection
Agency},city={Durham},country={USA},countrysep={,},postcodesep={}}
\affiliation[2]{organization={Office of Chemical Safety and Pollution
Prevention (OSCPP), US Environmental Protection
Agency},city={DC},country={USA},countrysep={,},postcodesep={}}

\cortext[cor1]{Corresponding author}















        
\begin{abstract}
Per- and Polyfluoroalkyl substances (PFAS) are a class of man-made
chemicals that are in widespread use and many present concerns for
persistence, bioaccumulation and toxicity. Whilst a handful of PFAS have
been characterized for their hazard profiles, the vast majority of PFAS
have not been extensively studied. Herein, a generalizable chemical
category approach was developed and applied to non-polymer PFAS that
could be readily characterized by a distinct chemical structure. The
PFAS definition as described in the TSCA Inactive Significant New Use
Rule (SNUR) was applied to the Distributed Structure-Searchable Toxicity
(DSSTox) database to retrieve an initial list of 10,576 candidate PFAS.
Plausible degradation products from the 617 PFAS on the non-confidential
TSCA Inventory were simulated using the Catalogic expert system, and the
unique PFAS degradants (3126) were added to the list resulting in a set
of 13702 candidate PFAS. Each PFAS was then assigned into a primary
category using Organisation for Economic Co-operation and Development
(OECD) structure-based classifications. The primary categories were
subdivided into secondary categories based on a chain length threshold
(\textgreater=7 vs \textless7). Secondary categories were subcategorized
using chemical fingerprints to achieve a balance between total number of
structural categories vs.~level of structural similarity within a
category based on the Jaccard index. A set of 85 structural categories
were derived from which a subset of representative candidates could be
proposed for potential tiered testing, taking into account
considerations such as the sparsity of relevant toxicity data within
each category as a whole, presence on environmental monitoring lists,
and the ability to identify plausible manufacturers/importers.
Refinements to the approach considering ways in which the categories
could be updated by new approach method (NAM) mechanistic data and
physicochemical property information are also described. This
categorization approach shows promise as a means to identify candidates
for testing with related applications in PFAS QSAR development, use of
read-across as well as targeted evaluation of PFAS.
\end{abstract}





\begin{keyword}
    Per- and Polyfluoroalkyl substances (PFAS) \sep Chemical
categories \sep read-across \sep New Approach Methods (NAMs) \sep tiered
testing \sep 
    Toxic Substances Control Act (TSCA)
\end{keyword}
\end{frontmatter}
    \ifdefined\Shaded\renewenvironment{Shaded}{\begin{tcolorbox}[borderline west={3pt}{0pt}{shadecolor}, boxrule=0pt, sharp corners, enhanced, interior hidden, frame hidden, breakable]}{\end{tcolorbox}}\fi

\setstretch{1.5}
\hypertarget{funding}{%
\section*{FUNDING}\label{funding}}
\addcontentsline{toc}{section}{FUNDING}

The work presented in this manuscript was solely supported by
appropriated funds of the US Environmental Protection Agency (US EPA).

\hypertarget{notes}{%
\section*{NOTES}\label{notes}}
\addcontentsline{toc}{section}{NOTES}

The views expressed in this manuscript are those of the authors and do
not necessarily reflect the views or policies of the US Environmental
Protection Agency (US EPA). Mention of trade names or commercial
products does not constitute endorsement or recommendation for use.

\hypertarget{introduction}{%
\section{Introduction}\label{introduction}}

\hypertarget{background}{%
\subsection{Background}\label{background}}

Per- and Polyfluoroalkyl substances (PFAS) are a large class of man-made
chemicals that have been manufactured and used in a variety of
industries since the 1940s
\citep{wang_never-ending_2017, gluge_overview_2020, gaines_historical_2023}.
PFAS have been or are currently being synthesized for a myriad of
different uses, including adhesives, stain resistant coatings for
clothes or furniture, fire retardants, and many more uses. In addition
to consumer and industrial applications, PFAS are being released into
the environment during manufacturing and use
{[}https://factor.niehs.nih.gov/2019/3/feature/2-feature-pfas{]}. PFAS
and products containing them are regularly disposed of in landfills or
incinerated which can also lead to further release into soil,
groundwater, and air \citep{chen_evaluation_2023, li_critical_2023}.
They are also found in biosolids from wastewater treatment facilities
which have been spread onto agricultural fields
\citep{bolan_distribution_2021};
{[}https://www.ewg.org/news-insights/news/2022/04/ewg-forever-chemicals-may-taint-nearly-20-million-cropland-acres{]}.

Characterizing the scope and scale of the `PFAS class' has been
challenging in the absence of a harmonized PFAS definition. Some have
cited thousands of PFAS being in the environment (estimates range from
4700 to greater than 9000) (See
https://www.scientificamerican.com/article/forever-chemicals-are-widespread-in-u-s-drinking-water/),
but there is likely to be an increasing number identified given that
analytical methods are continually being evolved to detect them. An
Organisation for Economic Co-operation and Development (OECD) working
group defined PFAS as `fluorinated substances that contain at least one
fully fluorinated methyl or methylene carbon atom (without any H/Cl/Br/I
atom attached to it); that is, any chemical with at least a
perfluorinated methyl group (--CF3) or a perfluorinated methylene group
(--CF2--)' \citep{oecd_reconciling_2021, wang_new_2021}. This broad OECD
definition would make estimates of a few thousand PFAS too low; however,
the OECD working group also acknowledges that a chemistry definition of
PFAS does not equate to how PFAS should be necessarily assessed in terms
of their hazard profile or to what extent subcategorizations of PFAS are
appropriate depending on different legislative frameworks. Indeed, if
the OECD definition were applied to a large inventory such as the US
EPA's Distributed Structure-Searchable (DSSTox) Database project
\citep{grulke_epas_2019} estimates of the number of PFAS would be in the
range of 30,000 members. For contrast, PubChem's Classification Browser
(https://pubchem.ncbi.nlm.nih.gov/classification/\#hid=120) has tagged
over 6.4 million substances as meeting the OECD PFAS definition. Any
substance containing a CF3 would be classified as a ``PFAS'' even though
it might fall within the remit of other regulatory frameworks. The US
EPA's Office of Pollution Prevention and Toxics (OPPT) recently proposed
a structural definition for defining PFAS for the purposes of a rule
that requires EPA review and approval prior to manufacturing and/or
processing a chemical substance meeting the definition that is not
currently ``active in U.S. commerce'' as provided by TSCA. This proposal
is known as the TSCA Inactive Significant New Use Rule (SNUR)
\citep{epa_2023}. This definition is narrower in scope than the OECD
chemistry definition yet still identifies several thousand PFAS
candidates. Under the proposed TSCA Inactive SNUR, a PFAS is defined as
`including at least one of three substructures: 1) R-(CF2)-CF(R')R'`,
where both the CF2 and CF moieties are saturated carbons; 2)
R-CF2OCF2-R', where R and R' can either be F, O, or saturated carbons;
and 3) CF3C(CF3)R'R'`, where R' and R'\,' can either be F or saturated
carbons. Of the many thousands of PFAS, few have been studied
extensively in terms of their toxicity profile. Beyond PFAS such as
perfluoroocanoic acid (PFOA) and perfluorooctane sulfonic acid (PFOS),
the vast majority of PFAS lack data to facilitate a robust
characterization of their potential toxicity
\citep{carlson_systematic_2022}. In an effort to address these data
gaps, Congress directed EPA (15 USC 8962) to develop a process for
prioritizing which PFAS or `class' of PFAS should be subject to
additional research efforts based on potential for human exposure to,
potential toxicity of, and other available information. This is
described in more detail in EPA's National Testing Strategy
{[}https://www.epa.gov/assessing-and-managing-chemicals-under-tsca/national-pfas-testing-strategy{]}
that was published in October 2021.

The notion of a `class' underpins grouping approaches which includes the
concept of developing categories to perform associated read-across.
Rather than assessing each PFAS individually, closely related PFAS could
be, in principle, grouped together into categories. Thus, in a category
approach, not every PFAS needs to be tested for every single endpoint.
Instead, the overall data for that category could potentially prove
applicable to support a hazard assessment for other members of the
category.

Grouping approaches have been in use in regulatory programmes for many
years dating back to 1998 when guidance was developed by the EPA in
support of the US High Production Volume (HPV) Challenge Program
(https://hero.epa.gov/hero/index.cfm/reference/details/reference\_id/1060798).
The concepts of grouping, categories and read-across are extensively
described in OECD's grouping guidance document, last revised in 2017
\citep{oecd_guidance_2017} and presently undergoing revision. Moreover,
the state of art in read-across has been described extensively in the
literature; from workflows which outline the steps undertaken to develop
category and analogue approaches through to the evaluation,
justification and documentation of the read-across prediction made
\citep{cronin_chapter_2013, escher_towards_2019, patlewicz_navigating_2018, patlewicz_towards_2023}.
More recently the notion of enhancing structure-based groupings with new
approach methods (NAMs) has also been an evolving topic, for example, to
what extent can structural categories be further justified by NAM data
by providing a mechanistic underpinning
\citep{escher_towards_2019, patlewicz_navigating_2018, patlewicz_towards_2022, patlewicz_towards_2023}.

This study describes the approach taken to further refine a relevant
PFAS landscape of interest to EPA from which an initial set of
structural categories were derived. The work here is a continuation of
the initial categorization efforts described in the EPA National Testing
Strategy. For the set of categories developed, the data gaps were
assessed to help identify which categories were particularly data poor
(e.g., lacking relevant repeat dose toxicity data) an/or associated with
known exposures and therefore would benefit from data collection or new
test data generation (using both NAMs or traditional approaches) to
better characterize the category as a whole. The aims of this manuscript
are as follows:

\begin{enumerate}
\def\labelenumi{\arabic{enumi}.}
\tightlist
\item
  Summarize the process of constructing a PFAS landscape;
\item
  Profile the PFAS landscape to assign substances into broad structural
  categories in combination with chain length;
\item
  Evaluate the degree of structural similarity within each category and
  determine which categories needed to be further subset to maximize
  their structural similarity whilst maintaining a pragmatic total
  number of categories;
\item
  Facilitate the identification of potential candidate PFAS for tiered
  testing by capturing additional considerations such as availability of
  a known manufacturer/importer; Agency and/or State priorities,
  environmental monitoring information and structural diversity within
  the category;
\item
  Evaluate the categories based on their predicted physical state and
  physicochemical properties;
\item
  Consider the utility of the structural categories developed in
  performing read-across, as well as refinements such as incorporating
  mechanistic and toxicokinetic data derived from NAMs. Separately, EPA
  has been leading a research programme to test a targeted set of
  \textasciitilde150 PFAS through an array of different NAM approaches
  as part of a category approach
  \citep{carstens_evaluation_2023, houck_bioactivity_2021, houck_evaluation_2023, kreutz_category-based_2023, patlewicz_towards_2022, smeltz_plasma_2023, smeltz_targeted_2023, stoker_high-throughput_2023}.
  The mechanistic insights derived from this parallel effort offer
  potential opportunities to refine the structurally-based categories
  developed.
\end{enumerate}

\hypertarget{methods}{%
\section{Methods}\label{methods}}

\hypertarget{sec-defining-pfas}{%
\subsection{Defining the PFAS landscape of
interest}\label{sec-defining-pfas}}

To define the PFAS landscape for the purpose of this study, the starting
point was to search the DSSTox database
\citep{grulke_epas_2019, williams_comptox_2017} using a series of
structure-based queries that capture the PFAS definition described in
the TSCA Inactive Significant New Use Rule (SNUR) \citep{epa_2023}.
DSSTox forms the basis of the EPA CompTox Chemicals Dashboard (referred
to herein as the Dashboard)
\citep{grulke_epas_2019, williams_comptox_2017} and comprises 1,200,059
substances (at the time of writing, March 2023).
(https://comptox.epa.gov/dashboard/). As a result of the search, 10,576
substances were identified as forming the initial PFAS landscape for
this study. This set was cross referenced with the TSCA inventory (see
Section~\ref{sec-lists}) to identify matches. For each of the TSCA PFAS,
degradation products were simulated using the biodegradation model,
Catalogic 301C v12.17 within the commercial software tool, OASIS
Catalogic v5.15.2.14 (University As Zlatarov, Laboratory of Mathematical
Chemistry, Bourgas, Bulgaria; http://oasis-lmc.org/). The set of PFAS
degradation products (3126) for the parent TSCA substances were added to
the initial landscape such that the final PFAS landscape used in this
study comprised 13,702 substances. Note only degradation products
meeting the SNUR definition were considered. Chemicals were represented
by unique DSSTox Substance Identifiers (DTXSID)
\citep{grulke_epas_2019}, Simplified Molecular-Input-Line-Entry System
(SMILES)
(https://www.daylight.com/dayhtml/doc/theory/theory.smiles.html),
chemical names and CAS Registry Numbers (CASRN). International Chemical
Identifier keys (InChIKeys), (hashed InChI) \citep{heller_inchi_2015}
were used as identifiers for the degradation products. Chemical
substances in the DSSTox database have been curated and standardized to
ensure correctness in chemical structure as well as their associations
to chemical names and other identifiers such as CASRN. Examples of this
curation include checking for errors and mismatches in chemical
structure formats and mapping to identifiers, as well as structure
validation issues like hyper-valency, tautomerism etc
\citep{grulke_epas_2019}.

\hypertarget{biodegradation-potential}{%
\subsection{Biodegradation potential}\label{biodegradation-potential}}

Biodegradation predictions were made for PFAS in the landscape that were
on the TSCA inventory using the Catalogic 301C v12.17 model within the
commercial software tool, OASIS Catalogic v5.15.2.14. The intent was to
enrich the landscape by substances more likely to be found in the
environment as they originated from substances in commerce. The
biodegradation Catalogic 301C model simulates aerobic biodegradation
under Ministry of International Trade and Industry, Japan (MITI) I (OECD
301C) test conditions. The modelled endpoint is the percentage of
theoretical biological oxygen demand (BOD) on day 28. The underlying
training set for the model comprises BOD data for 2620 substances -- 745
of these were collected from the MITI I database and 806 were provided
by National Institute of Technology and Evaluation (NITE), Japan. A
further 1069 substances that were proprietary were provided by NITE,
Japan. In addition to BOD data, a second database underpinning the model
comprised pathways for 783 organic substances, documented pathways for
587 chemicals were collected from the primary and secondary literature
whereas pathways for 196 proprietary substances were provided by NITE,
Japan. In brief, the Catalogic model comprises a metabolic simulator and
an endpoint model. The microbial metabolism is simulated by a rule-based
approach based on a set of hierarchically ordered transformations and a
system of rules controlling the application of these transformations.
Recursive application of the transformations allows for the simulation
of metabolism and generation of biodegradation pathways. Calculation of
the modelled endpoint is based on the simulated metabolic tree and the
material balance of transformations used to build the tree. Predictions
were made for all PFAS in the landscape that were on the
non-confidential TSCA inventory (see Section~\ref{sec-lists} for more
details). Prediction results containing the list of simulated
metabolites (as SMILES) along with their DTXSID identifiers were
exported as a text file. Prediction results were then processed in the
following manner:

\begin{enumerate}
\def\labelenumi{\arabic{enumi}.}
\tightlist
\item
  DTXSID identifiers were extracted for each parent substance and mapped
  to each metabolite. This ensured for a given parent, all metabolites
  could be readily associated with its corresponding parent substance.
\item
  A new identifier was then created for the metabolites based on the
  parent DTXSID identifier. That is to say, the first metabolite
  simulated for parent DTXSID9065256 would be tagged as
  DTXSID9065256\_m\_1 and so on. This would provide an approximate means
  of tracking where in the simulated pathway a metabolite appeared and
  which parent it was associated with.
\item
  SMILES that were generated by OASIS software are non-standard in their
  format and not readable by other cheminformatics software. This was a
  major limitation as without standardization, no further computation
  whether that be assigning metabolites to OECD categories or
  calculating any properties was possible. Using a series of manual
  \emph{ad hoc} rules, the SMILES generated by the OASIS Catalogic
  software were converted to a standardized form. This involved
  transforming stereochemistry annotations and salt form (cation and
  anion) representations.
\item
  InChIKeys were then generated for all standardized SMILES, parents and
  simulated metabolites. Use of InChIKeys provided an unambiguous means
  of structurally representing the substance (rather than using SMILES
  that are potentially non-unique) and enabled subsequent associations
  to be derived between substances. The processed results were saved for
  subsequent analysis.
\end{enumerate}

Many degradation products were found to be common across parent
substances. Grouping by InChIKeys created a set of unique degradation
products. These were filtered to remove non PFAS degradation products
leaving a set of 3126 degradation products that were added to the
starting landscape of 10,576 substances.

To explore the coverage and relevance of the MITI training set within
the Catalogic 301C model relative to the PFAS on the TSCA inventory
substances, a comparison was performed to evaluate the number of PFAS
substances within the training set as well as to assess the overlap in
structural space as characterized by Morgan chemical fingerprints
\citep{rogers_extended-connectivity_2010} (see
Section~\ref{sec-fingerprints} for details on chemical fingerprint
generation). In the latter case, this structural space was projected
onto a 2-dimensional (2D) scatterplot (see Figure~\ref{fig-miti}) using
a t-distributed stochastic neighbor embedding (t-SNE) to facilitate
visualization \citep{van_er_maaten_visualizing_2018}.

\hypertarget{profiling-pfas-into-categories}{%
\subsection{Profiling PFAS into
categories}\label{profiling-pfas-into-categories}}

\hypertarget{sec-primary-categories}{%
\subsubsection{Primary structural
categories}\label{sec-primary-categories}}

This study aimed to develop a hierarchy of PFAS categories starting with
a handful of large, diverse categories that could be subcategorized into
more structurally similar categories based on other considerations
(e.g., chemical fingerprints, chain length). To that end, primary
categories were derived by profiling the PFAS landscape of 13,702
substances through the database framework developed by Su and Rajan
\citep{su_database_2021} called ``PFAS-Map''
(https://github.com/MatInfoUB/PFAS\_Map\_MaDE\_UB). As described in Su
and Rajan \citep{su_database_2021}, PFAS could be classified into one of
at least nine broad primary categories:

\begin{itemize}
\tightlist
\item
  PFAS derivatives
\item
  PFAAs
\item
  PFAA precursors
\item
  Non-PFAA perfluoroalkyls
\item
  FASA-based PFAA precursors
\item
  Fluorotelomer-based PFAA precursors
\item
  Silicon PFAS
\item
  Side-chain fluorinated aromatics PFAS
\item
  Other aliphatic PFAS
\end{itemize}

PFAAs makes reference to perfluoroalkyl acids whereas FASA denotes
perfluoroalkane sulfonamides. The PFAS landscape was also processed
through the OPEn structure-activity/property Relationship App (OPERA)
v2.8 tool \citep{mansouri_opera_2018}
(https://github.com/kmansouri/OPERA) to derive QSAR READY SMILES and
selected physicochemical property predictions (as discussed in Section
Section~\ref{sec-physchem}). These are standardized SMILES where salts
and stereochemistry are removed. QSAR READY SMILES could be generated
for 13,449 substances of the PFAS landscape. Substances without QSAR
READY SMILES or which could not be computationally resolved were
assigned as ``Unclassified''. In practice, when substances are batch
processed by PFAS-Map, a first class and second-class classification are
designated. For this study, the first-class designation was used as the
initial primary category assignment which was then converted using a
simple mapping dictionary to ensure that substances such as
``Fluorotelomer PFAA precursors, cyclic'' were aggregated to
``Fluorotelomer PFAA precursors''. This was performed to limit the
number of primary structural categories which themselves were largely
consistent with the hierarchy described by OECD in their Terminology
2021 guidance \citep{oecd_reconciling_2021}.

\hypertarget{secondary-structural-categories}{%
\subsubsection{Secondary structural
categories}\label{secondary-structural-categories}}

It is hypothesized that the length of carbon chain influences
differences in toxicity and the length of time the chemical spends in
the body and environment. This supposition has been underpinned by
experiences with PFAAs
\citep{chambers_review_2021, sznajder-katarzynska_review_2019}. Due to
the potential importance of chain length in the toxicity, persistence
and bioaccumulation of PFAS, secondary structural categories were
defined using a carbon chain length threshold.

\emph{Chain length determination}

The maximum number of contiguous CF2 groups in a chain was determined
for all 13,702 substances. This was achieved by iterating through a
range of CF2 chain lengths and determining the longest chain length
where there was a match with the corresponding substance. For instance,
Perfluorosebacamidine {[}DTXSID40380015{]} contains 8 contiguous CF2
units; hence, its chain length was denoted as 8. PFOA had a maximum
chain length of 7 whereas PFOS had a maximum chain length of 8. For
PFOA, although there are 8 carbons in its backbone, the 8th is part of
the carboxyl group whereas in PFOS, there are 8 CF2 groups plus the
sulfonate group.

For the current analysis, the chain length threshold was set at 7
(\textgreater=7 vs \textless7). This threshold served as a pragmatic
representation of what constitutes a ``long chain'' PFAS. The chain
length threshold is broadly consistent with the EPA's 2009 PFAS action
plan
(https://www.epa.gov/sites/default/files/2016-01/documents/pfcs\_action\_plan1230\_09.pdf).
A PFAS with a maximum CF2 number greater than or equal to 7 was denoted
``gte7''. Using this threshold, both PFOS and PFOA would be assigned to
the ``gte7'' secondary category. A PFAS with a maximum number of CF2
groups less than 7 was denoted ``lt7''. Defining chain lengths for PFAS
with non-contiguous chains or branching is less clear but has been
evaluated in more detail by Richard et al
\citep{richard_identification_2022, richard_new_2023} through the
development of new PFAS specific chemical fingerprints, so-named PFAS
ToxPrints, as an extension of the logic used to develop the original
ToxPrints that had been defined for a broader chemistry
\citep{yang_new_2015}.\\
A secondary category was thus denoted by its PFAS-Map assignment, akin
to the primary OECD structural classification and a carbon chain length
threshold e.g., Perfluorooctanesulfonamidoacetic acid
{[}DTXSID40440941{]} would thus be described as belonging to the ``FASA
based PFAA precursors, gte7'' secondary category.

\hypertarget{sec-term-cat}{%
\subsubsection{Terminal structural categories}\label{sec-term-cat}}

The underlying motivation for the study was to identify categories that
would balance maximizing structural similarity that could permit
read-across within those categories versus pragmatism in terms of total
number of categories. Too many categories with very few substances
renders the approach less generalizable, too few categories could result
in extrapolating between substances that were not sufficiently similar.
To that end, an objective threshold was needed to determine how granular
categories needed to be to manage this trade-off and ensure that the
categorization was actionable. An objective threshold was developed,
described in Section~\ref{sec-objective-threshold}, that compared
structural similarity within a category relative to the structural
similarity between different categories.

\hypertarget{sec-fingerprints}{%
\subsection{Chemical fingerprints}\label{sec-fingerprints}}

Morgan chemical fingerprints \citep{rogers_extended-connectivity_2010}
were calculated for all substances within each secondary category using
the open-source Python library RDkit (Landrum, rdkit.org) with a radius
of 3 and a bit-length of 1024. Fingerprints capture presence (denoted by
1) and absence of features (denoted as 0) and hence, by their nature
they represent a binary dataset. These fingerprint (FP) files were
stored for subsequent processing. Morgan fingerprints also known as
Extended Connectivity Fingerprints (ECFPs) are widely used in machine
learning applications for cheminformatics \citep{oboyle_comparing_2016}
especially when ranking diverse structures by similarity. These circular
fingerprints map the molecular environment of every atom.

\hypertarget{sec-chem-sim}{%
\subsection{Chemical similarity}\label{sec-chem-sim}}

Pairwise distance matrices were calculated for each secondary category.
These were generated by using the chemical fingerprint files as inputs
and computing the Jaccard distance for each pair of substances. The
Jaccard distance captures the proportion of FP bits between 2 substances
that differ (https://en.wikipedia.org/wiki/Jaccard\_index). The Jaccard
distance ranges from 0 to 1 where 0 would indicate zero distance (or
high similarity) and 1 would indicate high distance (or low similarity).

Distance matrices were computed for all secondary categories and stored
for subsequent processing. These are referred to as `within category'
distance matrices in Section~\ref{sec-objective-threshold}.

\hypertarget{sec-objective-threshold}{%
\subsection{Objective distance
threshold}\label{sec-objective-threshold}}

The rationale underpinning the objective distance threshold was based on
the expectation that the variance in the distribution of the pairwise
distances for each secondary category representing the `within category'
similarity would be lower than distributions of the pairwise distances
between different secondary categories (`between category'). The `within
category' distances had already been computed as described in
Section~\ref{sec-chem-sim}.\\
`Between category' combinations aimed to identify categories that did
not share the same primary category root. A list of all possible binary
combinations of secondary categories was created using the names of the
secondary categories, ``Other aliphatics, lt7'' and ``PFAAs, gte7'' is
an example of such a binary combination. These were then filtered to
remove secondary categories that shared the same primary category root
(i.e., a combination such as ``PFAAs, lt7'' and ``PFAAs, gte7'' would be
excluded from consideration as a `between category'). Chemical
fingerprint datasets for each binary combination were created by joining
the secondary category chemical fingerprint datasets together. Pairwise
distance matrices were then derived for the combined category set. These
were filtered to retain only the pairwise distances between starting
secondary categories.

The empirical cumulative distribution functions (ECDFs) of the pairwise
distances were calculated for each secondary category (see
Figure~\ref{fig-ecdfs-within} for a plot of the ECDFs). ECDFs were also
derived for the `between category' combinations (see
Figure~\ref{fig-ecdfs-bet} for a plot of the first 10 ECDFs). The ECDFs
permitted a visual inspection of the range of the pairwise distances
across all secondary categories as well as across all `between category'
combinations. Based on visual inspection of the ECDFs, the median value
for each distribution was selected as the summary metric.\\
Probability density functions of median values from all within and
between secondary categories were plotted to explore their overlap. The
5th percentile of the `between categories' distribution was defined as
the threshold to determine whether a secondary category merited further
subcategorization. A secondary category was only subcategorized if the
median of its `within category' pairwise distance distribution exceeded
this threshold.

\hypertarget{sec-terminal}{%
\subsection{Terminal categories}\label{sec-terminal}}

Secondary categories that exceeded the threshold were subcategorized
using agglomerative hierarchical clustering. The condensed form of the
pairwise distance matrix computed for each secondary category that
exceeded the threshold was used as an input into a hierarchical
clustering using Ward's method \citep{ward_hierarchical_1963}. Ward's
method is a criterion that minimizes the total within-cluster variance.
For each secondary category, the dendrogram was plotted and the number
of first-generation clusters was set as the maximum cluster number.
Clusters were labelled as 1,2,3 etc. Each of the clustering results were
combined into one table which was then merged with the starting table of
primary and secondary categories.

The next generation of categories, quaternary categories, would then be
processed in the same manner to determine whether any exceeded the
objective threshold and needed to be subcategorized further as already
described. In practice, a maximum of two generations of
subcategorizations were performed, with the expectation that this would
balance the structural similarity within the category relative to total
number of terminal categories.

Secondary categories or tertiary categories which did not exceed the
threshold were ultimately denoted as the terminal category. Thus, a
terminal category could be tagged as ``PFAA, lt7'', effectively a
secondary category, or could be tagged as ``Other aliphatics, lt7, 1'',
a tertiary category or following two iterations of subcategorization
would be tagged as ``Other aliphatics, gte7, 1, 2''. Note: in the data
files and figures, terminal categories without one or two iterations of
subcategorization are denoted as ``PFAA, lt7, nan, nan'' or ``Other
aliphatics, lt7, 1, nan'' where ``nan'' represents a null value.

The conceptual workflow for creating the PFAS structural categories is
summarized in Figure~\ref{fig-categorisation}.

\begin{figure}

{\centering \includegraphics[width=1\textwidth,height=\textheight]{PFAS_categorisation.png}

}

\caption{\label{fig-categorisation}Conceptual workflow for generating
PFAS structural categories}

\end{figure}

\hypertarget{sec-centroid}{%
\subsection{Centroid calculation}\label{sec-centroid}}

For each terminal category, a single substance was identified that was
nominally representative of the category. This substance was the
computed centroid calculated from the Jaccard pairwise distance matrices
(see Section~\ref{sec-chem-sim}). The sum of the pairwise distances
across all substances for a given structural category was computed and
the substance with the minimum value was denoted as the centroid (i.e.,
this substance would have the lowest distance from all other category
members). Technically, this calculation gives rise to the medoid of a
cluster. However, for the purposes of this analysis, the term centroid
is used for convenience to denote it as the `middle' substance within
the category. Distances of all category members relative to the centroid
substance were also computed.

\hypertarget{sec-maxmin}{%
\subsection{Selecting additional candidates beyond
centroids}\label{sec-maxmin}}

Since many of the terminal categories were likely to be large in size, a
single substance might be insufficient to both characterize the category
and its potential hazard profile. To address this limitation, the
MaxMinPicker approach, as implemented within the RDKit Python library,
was applied to identify additional substances which would in turn
capture the breadth and diversity of each category
\citep{ashton_identification_2002}. The MaxMinPicker approach proceeds
as follows:

1. Molecular descriptors are generated for all substances. In this case,
the Morgan fingerprints calculated for all substances within a terminal
category represented the candidate pool whereas the pre-computed
centroid equated to the initial seed.

2. From the substances in the terminal category, the substance that had
the maximum value for its minimum distance to the picked set (initially
this would be just the centroid) would then be identified. This
substance would be the most distant one to those already picked so it
would be transferred to the `picked set' (now centroid + 1).

3. An iteration back to step 2 would then be performed until the desired
number of substances were picked.

The MaxMin approach is a well-established algorithm for
dissimilarity-based compound selection that has been applied in drug
discovery for many years. the reader is referred to Snarey et al
\citep{snarey_comparison_1997} for a comparison of the different
algorithms.

The MaxMinPicker was applied to all terminal categories containing more
than 5 members to select the next 3 most diverse substances within a
category (centroid + up to 3 additional substances). The intention of
picking additional diverse substances was to help bound the domain of
the structural category. The selection of 3 most diverse substances was
chosen out of convenience to propose an actionable number of additional
substances. A systematic evaluation of the relationship between the
number of diverse substances that could be picked relative to the
structural diversity within each terminal category was also undertaken.
This was approached as follows, first the ranked order by diversity of
all members within a terminal category was computed. Then the pairwise
distance matrices derived in Section~\ref{sec-chem-sim} were filtered by
the diverse substances, starting from the centroid, centroid plus first
diverse chemical through to the complete set of category members. At
each step the mean minimum distance was recorded. This enabled the
construction of a matrix to capture the mean of the minimum pairwise
distances relative to the number of diverse chemicals selected. The
normalized cumulative sum of all the mean minimum distances was then
computed. This provided a means of evaluating the proportion of
structural diversity that was captured as a function of the number of
MaxMin substances selected.

Two aspects could be assessed objectively from this calculation, namely:

1. how much structural diversity was being captured by the 3 diverse
picks originally identified; and

2. how many diverse substances should ideally be selected (if practical
resources were not a limiting factor) that would capture a specified
level of the structural diversity. For example, how many substances
would need to be selected if capturing a specific percentage of the
structural diversity within a terminal category was desired, 80\% is
presented for illustrative purposes.

\hypertarget{facilitating-the-identification-for-potential-candidates-for-tiered-testing}{%
\subsection{Facilitating the identification for potential candidates for
tiered
testing}\label{facilitating-the-identification-for-potential-candidates-for-tiered-testing}}

To facilitate the identification of potential candidate PFAS for tiered
testing, availability of a known manufacturer/importer, Agency and/or
State priorities, environmental monitoring information were evaluated as
additional considerations. These are described in turn.

\hypertarget{sec-lists}{%
\subsection{Qualitative list designations}\label{sec-lists}}

Several indicators were added to the landscape to identify substances
based on their TSCA inventory status, Chemical Data Reporting under
TSCA, or State/Region priorities.

The non confidential (Non-CBI) TSCA Inventory active and inactive lists
were downloaded from the Dashboard and combined into one large set.
Substances within this inventory are annotated by Chemical Abstract
Service (CAS) Registry Number, Chemical Abstracts (CA) Index Name, and
DSSTox substance identifier (DTXSID). These were matched by the DTXSID
identifiers already captured in the PFAS landscape. Substances were
tagged as `inactive', `active' or `unclassified'. Note the predicted
degradation products of substances tagged as either ``inactive'' or
``active'' had been used to augment the PFAS landscape as already
described in Section~\ref{sec-defining-pfas}.

The CDR data from 2020 was downloaded from the public EPA web address
(https://www.epa.gov/chemical-data-reporting/access-cdr-data). The data
is structured in several files depending on the granularity of
information captured. The CDR data comprises information for a set of
8660 substances. DTXSID identifiers were available for 8017 of these
substances when using the Batch search functionality within the
Dashboard. A tag was created for CDR2020 status if a PFAS was found to
be associated with a CDR record. National Aggregated Production Volume
(National Agg PV) data was also extracted to highlight how this was
distributed across primary categories. Since some of the production
volume (PV) data was numeric and some represented in numeric ranges, the
PV data was summarized into one of 10 different ranges (\textless25,000
lbs, \textless1,000,000 lbs, 25-\textless100,000 lbs, 100,000
\textless500,000 lbs, 500,000 -\textless1,000,000 lbs, 50,000,000
-\textless100,000,000 lbs, \textless1,000,000 lbs, 100,000,000
-\textless{} 1,000,000,000 lbs, 20,000,000 -\textless{} 100,000,000 lbs,
1,000,000 -\textless{} 20,000,000 lbs, 1,000,000 -\textless10,000,000
lbs).\\

Various Regions or States have identified PFAS of interest based on
validated analytical methods or for environmental monitoring purposes.
The data sources captured as part of the EPA's PFAS Analytic Tools
website (https://echo.epa.gov/trends/pfas-tools\#data) were used to
construct lists of such PFAS. The specific data sources were Discharge
Monitoring Data, Drinking Water (State) Data, Drinking Water (UCMR)
Data, Environmental Media Data, Production Data, Toxics Release
Inventory (TRI) Data -- Waste Managed, TRI Data -- On-Site, TRI Data --
Off-Site and Production Data (all accessed 7th April 2023). Discharge
Monitoring data is collected by virtue of the National Pollutant
Elimination System permit. Drinking Water Data comprises UCMR,
Unregulated Contaminant Monitoring Rule data and State level monitoring
data. Environmental Media data comprises ambient sampling data reported
by federal, state, tribal and local governments, academic and
non-governmental organizations, and individuals that are submitted to
the Water Quality Portal (WQP). Production data entails information
reported under the Chemical Data Reporting (CDR) Rule under TSCA. TRI
tracks the management of certain toxic chemicals that may pose a threat
to human health or the environment by more than 21,000 facilities
throughout the US and its territories. The National Defense
Authorization Act of Fiscal year 2020 (NDAA) added certain PFAS to the
TRI list and provided a framework for the ongoing listing of additional
PFAS.\\
Identifiers were extracted from these source files and searched against
the Dashboard to map to DTXSID records. The set of identifiers (Names
and CASRN) within the entire PFAS landscape were also queried against
PubMed, the National Library of Medicine's citation index for biomedical
literature to determine whether a substance might have been studied in
the literature. This was queried using the Landscape feature within the
Abstract Sifter v7.5 \citep{baker_abstract_2017}. Each of these
respective priorities were then matched to the PFAS landscape to provide
another attribute for consideration when selecting potential candidates
for testing.

\hypertarget{sec-constrained}{%
\subsection{Constrained PFAS Landscape}\label{sec-constrained}}

One of the main limitations of the identification of centroids and
additional diverse substances was that they might yet not yield feasible
candidates due to the lack of assignable manufacturer/importer. This was
articulated as potential challenge in the Testing Strategy. To address
this practical constraint, the same process of computing centroids,
identifying additional diverse substances and evaluating their
structural diversity coverage was also performed using the terminal
categories as a basis as described in Section~\ref{sec-terminal} but
constraining the landscape to only those substances on the TSCA
inventory and specifically those substances that were actives on the
TSCA inventory. This would provide some more flexibility in terms of
selecting substances for testing that were already in commerce and/or
could be more readily procured.

\hypertarget{sec-physchem}{%
\subsection{Evaluation of predicted physicochemical
properties}\label{sec-physchem}}

The route of exposure and the types of toxicological tests that may be
needed to understand the health risks associated with a substance is
partly dependent on the physical state and physicochemical properties.
Physicochemical properties were predicted using the open-source OPERA
v2.8 tool \citep{mansouri_opera_2018} for all substances with QSAR READY
SMILES. Predictions were possible for 13,449 substances in the PFAS
landscape (as discussed in Section~\ref{sec-primary-categories}).
Properties predicted were melting point, boiling point, Henry's Law
constant (HLC), water solubility and vapour pressure. For the physical
state, a melting point less than 25 deg C would be indicative of a
liquid whereas a value greater would be a solid and a boiling point less
than 25 deg C would be a gas. These are the guiding principles
underpinning the EPA's Sustainable Futures Framework guidance (see
https://www.epa.gov/sites/default/files/2015-05/documents/05-iad\_discretes\_june2013.pdf).
A water solubility threshold of 100 mg/L was used to denote whether a
substance was soluble/insoluble whereas a vapour pressure threshold of
75 mmHg or a HLC of 0.1 atm m3 mol-1 determined volatility. Based on
these properties, each substance was assigned into 1 of 4 `physchem
testing tracks' (from A-D). Track A aimed to capture substances that
were insoluble solids, B to identify both soluble solids and soluble
non-volatile liquids, whereas C tagged soluble volatile
liquids/insoluble liquids and soluble gases. Track D assigned substances
as insoluble gases or highly volatile gases. Substances that could not
be assigned into one of these 4 tracks was tagged with a `no testing
track' flag. For each of the terminal structural categories, Morgan
fingerprint representations were projected into two dimensions using a
t-distributed stochastic neighbor embedding (t-SNE) to facilitate
visualization \citep{van_er_maaten_visualizing_2018}. The projections
were plotted as 2D kernel density distributions overlaid with physchem
testing track information to help explore the extent to which members
were assigned to the same track and therefore had a consistent physchem
profile across a given terminal category.

\hypertarget{sec-invivo}{%
\subsection{\texorpdfstring{Evaluation of variance of \emph{in vivo}
toxicity within terminal
categories}{Evaluation of variance of in vivo toxicity within terminal categories}}\label{sec-invivo}}

Ultimately, read-across of data within categories could be performed
such that the hazard profile of the category is adequate without needing
to test a significant number of category members. To evaluate the
feasibility of performing read-across within the terminal categories
derived, an exploration of the distribution of \emph{in vivo} points of
departure (PODs) within and across terminal categories was performed for
2 routes of exposure; oral and inhalation.

\hypertarget{sec-rax}{%
\subsubsection{\texorpdfstring{Variance of \emph{in vivo} PODs across
and within terminal
categories}{Variance of in vivo PODs across and within terminal categories}}\label{sec-rax}}

From ToxValDB version 9.4, the Toxicity Values Database (Judson et al.,
\emph{in prep}), all studies where `oral' or `inhalation' was the route
of exposure were extracted. Only records where a point of departure was
reported as a NOEL, NOAEL, NOAEC, LOAEL, LOEL, LOAEC and where the dose
units were expressed as mg/kg-bw/day or mg/m3 were retrieved. Study
types were also restricted to the following: `chronic', `developmental',
`reproduction', `reproduction developmental', `subchronic',
`neurotoxicity', and `short-term' as captured in the `study type' field
within the database. The toxicity data extracted for each route of
exposure was then merged with the PFAS substances from the landscape.
The minimum study-level point of departure (POD) was taken. Aggregating
all minimum values to a single value per substance depended on the
availability of NOAEL(C)-type or LOAEL(C)-type data and was performed as
follows. Minimum NOEL(C)/NOAEL(C) values were preferentially used for a
substance but if these were not available, LOEL(C)/LOAEL(C) values were
taken and adjusted by a factor of 10. The 10th percentile of all values
was then reported for a substance irrespective of its study type or
duration. Whilst the approach of aggregating the available information
across study types and durations is a simplified assumption, the summary
value provides an estimate of the POD for each substance and the
expected level of variation across and within categories. Box and
whisker plots were created to reflect the distribution of the PODs
across the terminal categories for each route of exposure. Strip plots
were overlaid to show the variation of chain length across a given
terminal category for the oral route of exposure. Inspection of the
plots was intended to facilitate a coarse grain evaluation of the extent
of the variation in PODs as a function of chain length and category.
PODs were plotted on a log scale.

\hypertarget{sec-nam-flag}{%
\subsection{Potential structure category refinements by considering
mechanistic and toxicokinetic data derived from NAMs: Qualitative NAM
flags}\label{sec-nam-flag}}

A summary of the NAM testing being undertaken for \textasciitilde150
PFAS was described in Patlewicz et al. \citep{patlewicz_towards_2022}.
See Houck et al. \citep{houck_bioactivity_2021} for results from various
nuclear receptor and oxidative stress targeted assays, Houck et al.
\citep{houck_evaluation_2023} for 12 human primary cell-based assay
models of pathophysiology including immunosuppression, Carstens et al.
\citep{carstens_evaluation_2023} for the developmental neurotoxicity
assays, and, for toxicokinetic information, Smeltz et al.
\citep{smeltz_plasma_2023} and Kreutz et al.
\citep{kreutz_category-based_2023}. Manuscripts describing the remaining
data streams (zebrafish developmental toxicity and thyroid pathway
assays) are in preparation.

In addition to the NAM testing, a quality control (QC) evaluation of the
High Throughput Screening (HTS) stocks was undertaken to confirm PFAS
analyte presence and stability \citep{smeltz_targeted_2023}. This
evaluation was warranted given recent reports of certain PFAS degrading
in the aprotic solvent dimethyl sulfoxide (DMSO), readily used as the
solvent of choice in HTS
\citep{liberatore_solvent_2020, zhang_stability_2022}. Two hundred and
five PFAS selected based on criteria described in Patlewicz et al.
\citep{patlewicz_towards_2022} were evaluated using low resolution
tandem mass spectrometric detection strategies to confirm presence of
intended analyte, evaluate analyte stability and presence of isomers,
and verify stock concentrations for a subset for which commercially
available verified standards were available. Ultimately 57 PFAS failed
QC evaluation, with three exhibiting degradation in DMSO and the
remainder not detected as present, likely due to volatilization. The
pass/fail scores and informational flags as described in Smeltz et
al.~{[}smeltz\_targeted\_2023{]}, and can be downloaded from
https://epa.figshare.com/articles/dataset/Chemistry\_Dashboard\_Data\_Analytical\_QC\_for\_PFAS/22118099.

For each of the NAM data streams, substances were tagged with a
qualitative flag to indicate the class of mechanistic information that
could be derived from the associated assay outcome (e.g., estrogen
receptor activity from a nuclear receptor assay) and an expert-derived
qualitative level of confidence associated with the outcome (high,
medium or low). Only NAM results from substances that passed QC were
carried forward. These flags were considered as an additional line of
evidence to determine whether a terminal category might merit being
split based on its mechanistic or toxicokinetic information or to inform
what types of higher order testing might be most impactful for a given
substance drawn from said terminal category. Each set of flags are
described in turn. Confidence scores across the NAM flags were
standardized as appropriate to facilitate visualizations across data
streams. Each flag could take on one of three values, low, medium and
high concern, color coded as blue, yellow and red. The flag categories
are summarized below in Table~\ref{tbl-nams}.

\hypertarget{tbl-nams}{}
\begin{longtable}[]{@{}
  >{\raggedright\arraybackslash}p{(\columnwidth - 6\tabcolsep) * \real{0.1000}}
  >{\centering\arraybackslash}p{(\columnwidth - 6\tabcolsep) * \real{0.3000}}
  >{\centering\arraybackslash}p{(\columnwidth - 6\tabcolsep) * \real{0.3000}}
  >{\centering\arraybackslash}p{(\columnwidth - 6\tabcolsep) * \real{0.3000}}@{}}
\caption{\label{tbl-nams}Summary of NAM Flag Rationales}\tabularnewline
\toprule\noalign{}
\begin{minipage}[b]{\linewidth}\raggedright
Technology
\end{minipage} & \begin{minipage}[b]{\linewidth}\centering
Low Concern (Blue)
\end{minipage} & \begin{minipage}[b]{\linewidth}\centering
Medium Concern (Yellow)
\end{minipage} & \begin{minipage}[b]{\linewidth}\centering
High Concern (Red)
\end{minipage} \\
\midrule\noalign{}
\endfirsthead
\toprule\noalign{}
\begin{minipage}[b]{\linewidth}\raggedright
Technology
\end{minipage} & \begin{minipage}[b]{\linewidth}\centering
Low Concern (Blue)
\end{minipage} & \begin{minipage}[b]{\linewidth}\centering
Medium Concern (Yellow)
\end{minipage} & \begin{minipage}[b]{\linewidth}\centering
High Concern (Red)
\end{minipage} \\
\midrule\noalign{}
\endhead
\bottomrule\noalign{}
\endlastfoot
Nuclear Receptors & No nuclear receptor activity & Activity against at
least one of the receptors ER, PPARA, PPARG, PPARD, NFE2L2, PXR, RARG,
RXRB at the level of two samples one assay or one sample in 2 orthogonal
assays. & Activity in the yellow medium concern that is confirmed using
the Eurofins assays \\
DNT & No activity or activity was only observed at the highest
concentration related to cytotoxicity & Low number of hits but which
demonstrated selective bioactivity & Moderate to high bioactivity (as
measured by hitcall) and demonstrated selective bioactivity (activity
below cytotoxicity AC50 as measured by AUC) and median AC50 \textless{}
10 M \\
Zebrafish & Development was normal in all larvae & Test results were
equivocal or if only 10-33\% of the larvae were affected & Positive
activity (i.e., elicited death, non-hatching, or malformations in at
least 50\% of the animals) \\
Thyroid & No activity greater than 50\% of the model inhibitors/binders
& Activity greater than 50\% of the model inhibitors/binder, but the
concentration necessary to result in this activity was 2 orders of
magnitude higher than the model inhibitors/binders & EC50s that were
within 2 orders of magnitude of the model inhibitors/binders \\
Immune & Selectivity scores less than 0.25 log10 M & Selectivity scores
of greater than 0.25 log10 M & \\
TK Plasma Binding (TK\_PlasBind) & TK\_PlasBInd\_High: Plasma protein
binding higher than 50\% of non-PFAS chemicals (f\_up \textless{} 0.11)
(this corresponds to 25th percentile of PFAS (fup\textless0.10) &
TK\_PlasBInd\_Higher: Plasma protein binding higher than 50\% of PFAS
chemicals (f\_up \textless{} 0.0109) & TK\_PlasBInd\_Highest: Plasma
protein binding higher than 75\% of PFAS (f\_up \textless{} 0.0039) \\
TK Intrinsic Clearance (TK\_Metab) & TK\_Metab\_Moderate: Clint in upper
75th percentile of exp PFAS data (Clint\textgreater5.97 ul/min/million
heps). Max Clint = 49.86 & TK\_Metab\_Slow: Clint \textless{} 5.97
ul/min/million cells (lower 75th percentile) & TK\_Metab\_Stable: Stable
in \emph{in vitro} hepatocyte incubation (Clint = 0 or Clint.pvalue
\textgreater{} 0.05) \\
TK\_Struc\_Endo & & Non-fluorinated structure is similar to endogenous
chemicals More likely to be a transporter substrate & \\
\end{longtable}

\hypertarget{in-vitro-assay-data-processing}{%
\subsubsection{\texorpdfstring{\emph{In Vitro} Assay Data
Processing}{In Vitro Assay Data Processing}}\label{in-vitro-assay-data-processing}}

All \emph{in vitro} data (excluding the toxicokinetic data) was
processed in a standard fashion, described here. Chemicals were run in
each assay in concentration-response, with a range from approximately
0.01-100 mM; in some cases, single-concentration screening preceded
multi-concentration screening to facilitate prioritization of chemicals
for screening. Data were processed through the ToxCast Pipeline (tcpl)
\citep{filer_tcpl_2017} (version 2.1.0) to generate
concentration-response curves and estimate potency and hitcall values.
Each concentration-response data set was fit to a constant, a Hill
curve, and a gain-loss model (combining a rising and a falling Hill
curve). The curve with the lowest Akaike Information Criteria (AIC) was
selected as the winner. If the winning curve was either a Hill or
gain-loss and the top of the curve exceeded a specified noise threshold,
the hitcall for the curve was set to 1 (active), and otherwise set to 0
(inactive) \citep{filer_tcpl_2017}. For most technologies, the potency
is expressed as the AC50 (50\% maximal activity value). The BioSeek
potency metric is a LEC (lowest effect concentration), which is the
first concentration at which the response exceeds the activity
threshold. The reason for this is that data are generated at only 4
concentrations. The Zebrafish developmental data was treated somewhat
differently, the open source R library tcplFit2 was used to curve-fit
the data \citep{sheffield_tcplfit2_2022}. This includes constant
(response=0), Hill, gain-loss, first- and second-order polynomials, a
power function and 2, 3, 4 and 5 parameter exponential models, and
continuous hitcall parameter that ranges from 0-1. For the purposes of
the current analysis, a hitcall \textgreater{} 0.9 was considered active
and hitcall  0.9 was inactive. With this application of tcplFit2, the
potency is expressed as a benchmark dose (BMD) based on a benchmark
response of 1.349 standard deviations from the median response of the
two lowest concentrations in the index. Unless otherwise noted, hitcalls
were not modified based on cytotoxicity considerations.

\hypertarget{nuclear-receptor-activity}{%
\subsubsection{Nuclear Receptor
Activity}\label{nuclear-receptor-activity}}

A total of 142 PFAS were evaluated for nuclear receptor activity using
an \emph{in vitro} screening platform that consisted of two multiplexed
transactivation assays in human hepatoma cell line HepG2, together
encompassing 81 diverse transcription factor activities via the Attagene
platform \citep{houck_bioactivity_2021}. Concentration-response modeling
was conducted as described above, with the design accommodating testing
concentrations up to 300 M, with assays run in both TRANS and CIS modes
in duplicate. Houck et al. \citep{houck_bioactivity_2021} reported
activity for the following nuclear receptors among the tested PFAS:
Estrogen receptor (ESR1), NRF2 (NFE2L2, a sensor for oxidative stress),
PPAR-alpha, -gamma and --delta (PPARA, PPARG, PPARD), PXR (NR1I2),
RXR-beta (RXRB) and RAR-gamma (RARG). In addition to the Attagene data
for the ESR1 target, Houck et al. \citep{houck_bioactivity_2021} also
provided information in the form of the human T-47D estrogen-sensitive
cell proliferation assay that was conducted using real-time impedance
measurement as the readout from ACEA Therapeutics, Inc.~(also up to 300
M). Confirmatory assays were run on subset of the hits in the initial
screen for ERS1, NFE2L2, PPARA, PPARAG, RXRB and RARG. This process used
orthogonal assays from Eurofins Inc.~(https://www.eurofins.com). More
details of this data are given elsewhere (Judson et al.~\emph{in prep}).
These assays used several different targeted technologies, including
cell-free assays that examine coactivator recruitment to indicate
receptor activation using fluorescence resonance energy transfer;
cell-based protein-protein interaction assays with receptor complex
activation indicated by radioligand detection; and a cell-based nuclear
factor erythroid 2-related factor (Nrf2) nuclear translocation assay
using chemiluminescence as a marker of increased oxidative stress
response (Table~\ref{tbl-nr}).

\hypertarget{tbl-nr}{}
\begin{longtable}[]{@{}
  >{\raggedright\arraybackslash}p{(\columnwidth - 4\tabcolsep) * \real{0.2500}}
  >{\centering\arraybackslash}p{(\columnwidth - 4\tabcolsep) * \real{0.2500}}
  >{\centering\arraybackslash}p{(\columnwidth - 4\tabcolsep) * \real{0.5000}}@{}}
\caption{\label{tbl-nr}Additional confirmatory assays from
Eurofins}\tabularnewline
\toprule\noalign{}
\begin{minipage}[b]{\linewidth}\raggedright
Target
\end{minipage} & \begin{minipage}[b]{\linewidth}\centering
Eurofins Assay Catalog Number
\end{minipage} & \begin{minipage}[b]{\linewidth}\centering
Item Name
\end{minipage} \\
\midrule\noalign{}
\endfirsthead
\toprule\noalign{}
\begin{minipage}[b]{\linewidth}\raggedright
Target
\end{minipage} & \begin{minipage}[b]{\linewidth}\centering
Eurofins Assay Catalog Number
\end{minipage} & \begin{minipage}[b]{\linewidth}\centering
Item Name
\end{minipage} \\
\midrule\noalign{}
\endhead
\bottomrule\noalign{}
\endlastfoot
ESR1 & 86-0003P-2452AG & ERalpha Human Estrogen NHR Cell Based Agonist
Protein-Protein Interaction Assay \\
ESR1 & 311410-0 & ERalpha Human Estrogen NHR Functional Agonist
Coactivator Assay \\
NFE2L2 (Keap1-Nrf2) & 86-0015P-2473AG & Keap1-Nrf2 Human Transcription
Factor Cell Based Agonist Nuclear Translocation Assay \\
PPARA & 86-0003P-2459AG & PPARalpha Human NHR Cell Based Agonist
Protein-Protein Interaction Assay \\
PPARA & 338210-0 & PPARalpha Human NHR Functional Agonist Coactivator
Assay \\
PPARA & 2811 & PPARalpha Human NHR Functional Agonist Coactivator
Assay \\
PPARG & 86-0003P-2460AG & PPARgamma Human NHR Cell Based Agonist
Protein-Protein Interaction Assay \\
PPARG & 338250-0 & PPARgamma Human NHR Functional Agonist Coactivator
Assay \\
PPARG & 2771 & PPARgamma Human NHR Functional Agonist Coactivator
Assay \\
RARG & 338800-0 & RARgamma Human Retinoic Acid NHR Functional Agonist
Coactivator Assay \\
RXRB & 338940-0 & RXRbeta Human Retinoid X NHR Functional Agonist
Coactivator Assay \\
\end{longtable}

PFAS selected for confirmation were required to meet minimal criteria
for activity in the initial screen. The substance was required to
satisfy one of two types of rules: ``single assay, multiple hits'',
meaning that the same endpoint was assessed with two independent samples
and both samples of the same chemical were active in the endpoint; or
``two assays same target'' where a single chemical sample was active in
both endpoints. The first rule could be satisfied by any one of the
Attagene (CIS or TRANS) or ACEA endpoints so long as the two independent
samples were positive in the same assay. The second rule could be
satisfied if both the Attagene CIS and TRANS endpoints were active for a
chemical-target pair for a single sample, or if one of the Attagene ESR1
endpoints and the ACEA ESR1 endpoint were together active for a single
replicate. Additionally, a substance had to have an average potency
\textless100 M, and with a Z-score of the potency relative to cytotoxic
burst \textgreater1 \citep{judson_editors_2016}.

For each assay, two blinded positive reference chemicals were assessed,
as well as two putative negatives. The positive reference chemicals were
selected based on public activity data in RefChemDB
\citep{judson_workflow_2019} and availability of samples in the current
ToxCast chemical inventory. This last constraint meant that some of the
positive controls were not the most potent available. The putative
negative chemicals were PFAS that had passed analytical QC, had shown
activity in some other nuclear receptor assays, but were negative in the
assays for which they were used as negative controls. Only assays with
activity in the positive reference chemicals were included. The counts
of chemicals tested and confirmed are given in Table~\ref{tbl-eurofins}.

\hypertarget{tbl-eurofins}{}
\begin{longtable}[]{@{}lll@{}}
\caption{\label{tbl-eurofins}Counts of active and inactive chemicals per
target in the confirmatory assays. A chemical was classified as active
if it was active in at least one of the confirmatory assays for the
target.}\tabularnewline
\toprule\noalign{}
Target & Active & Inactive \\
\midrule\noalign{}
\endfirsthead
\toprule\noalign{}
Target & Active & Inactive \\
\midrule\noalign{}
\endhead
\bottomrule\noalign{}
\endlastfoot
ESR1 & 11 & 9 \\
NFE2L2 & 1 & 2 \\
PPARA & 6 & 2 \\
PPARG & 1 & 1 \\
RARG & 0 & 2 \\
RXRB & 0 & 3 \\
\end{longtable}

For this analysis, all of the original nuclear receptor actives were
included as medium flags (``yellow''), but those that confirmed using a
Eurofins assay were elevated to high concern (``red''). An additional
three substances were active in both Attagene ESR1 endpoints and the
ACEA endpoint, and these were flagged as having higher confidence
(``red''). PFAS that were inactive in Attagene and ACEA were given low
(``blue'') flags.

\hypertarget{developmental-neurotoxicity-dnt-activity}{%
\subsubsection{Developmental Neurotoxicity (DNT)
Activity}\label{developmental-neurotoxicity-dnt-activity}}

A set of 160 PFAS were screened in a DNT assay battery, including four
assays from two assay technologies: the microelectrode array (MEA)
technology and the high-content imaging (HCI) technology. The assays
modelled four distinct neurodevelopment processes: proliferation,
apoptosis, neurite outgrowth, and neural network formation
\citep{carstens_evaluation_2023}. The MEA neuronal network formation
assay includes 17 endpoints measuring decreased neuronal network
development and function and 2 endpoints measuring cytotoxicity. The HCI
assays different cell-based models of neural cells to evaluate
proliferation, apoptosis, and neurite outgrowth in 8 different endpoints
\citep{carstens_evaluation_2023}.

DNT bioactivity flags were determined using several metrics, including
hitcall determination, potency as the AC50, and selective bioactivity
(activity occurring below the cytotoxicity threshold as defined by
concurrently run cytotoxicity assays). Based on these three metrics, a
chemical was binned into one of four flag categories: 0 -- inactive or
equivocal, 1 -- non-selective bioactivity, 2 -- low selective DNT
activity and 3 -- clear selective DNT bioactivity. Clear DNT bioactivity
was assigned a level 3 (high confidence) if there was moderate to high
bioactivity (as measured by hitcall) and demonstrated selective
bioactivity (activity below cytotoxicity AC50 as measured by AUC) and
median AC50 \textless{} 10 M. Low DNT activity was assigned a 2
(moderate confidence) if there were a low number of hits but which
demonstrated selective bioactivity. Non-selective DNT bioactivity
assigned a 1 (low confidence) if activity was only observed at the
highest concentration related to cytotoxicity. Inactive or equivocal
assigned a 0 were for zero hits or borderline curves determined to be
inactive by expert review.\\
For the current analysis, chemicals with inactive or equivocal results
were set to low concern (``blue''), chemicals with non-selective DNT
bioactivity were set to medium concern (``yellow''), and those with
clear DNT bioactivity were flagged as of high concern (``red'').

\hypertarget{zebrafish-activity}{%
\subsubsection{Zebrafish Activity}\label{zebrafish-activity}}

Developmental toxicity was assessed using a zebrafish embryo assay in
which zebrafish embryos were exposed to each chemical until the larval
stage \citep{padilla_zebrafish_2012}; Britton et al., \emph{in prep}.
The larvae were then assessed for death, non-hatching and malformations
(swim bladder non-inflation, craniofacial abnormalities, edema, spinal
curvature, blood pooling, abnormal position in the water column, or
abnormal pigmentation). The developmental toxicity of many of the
chemicals were assessed twice: once in a single, high-concentration,
preliminary, range-finding assay, and then again in a
concentration-response assay. The flag levels were then assigned to each
chemical according to the incidence (\%) of adversely affected larvae
for each chemical. Chemicals that were positive (i.e., elicited death,
non-hatching, or malformations in at least 50\% of the animals) were
assigned a high concern flag (``red''). If the development was normal in
all larvae, the low concern flag was assigned (``blue''). Chemicals that
affected some embryos, but less than 50\%, were assigned the medium
concern flag (``yellow'').

\hypertarget{thyroid-target-activity}{%
\subsubsection{Thyroid Target Activity}\label{thyroid-target-activity}}

The potential impacts of PFAS compounds on the thyroid axis were
assessed using medium-throughput assays which rely on human recombinant
enzymes.\, The assays test seven Molecular Initiating Events (MIEs) in
the thyroid Adverse Outcome Pathways (AOPs) network.\, This suite of
assays covers critical pathways within the thyroid axis including
deiodinase enzymes (Human Deiodinase 1,2 and 3, Human Iodotyrosine
deiodinase \citep{olker_screening_2019, olker_vitro_2021}), human
thyroid peroxidase \citep{paul_friedman_tiered_2016}, and thyroid
hormone plasma binding proteins (transthyretin, and thyroxine binding
globulin \citep{montano_new_2012}). The MIEs link to 16 known or
putative pathways in the AOP Wiki (https://aopwiki.org/aops, Society for
the Advancement of AOPs, 2020).

The flags for the thyroid chemicals were set as follows, based on
potency (AC50 values) and efficacy. Low concern (``blue'') chemicals had
no activity greater than 50\% of the model inhibitors/binders. Medium
concern chemicals (``yellow) had efficacy greater than 50\% of the model
inhibitors/binder, but the corresponding AC50 was at least 2 orders of
magnitude higher than the model inhibitors/binders. High concern
chemicals (red) had AC50s that were within 2 orders of magnitude of the
model inhibitors/binders.~

\hypertarget{immunosuppression-relevant-bioactivity}{%
\subsubsection{Immunosuppression-Relevant
Bioactivity}\label{immunosuppression-relevant-bioactivity}}

The BioMAP panel, comprising 12 different assay systems, has been used
previously, largely in preliminary toxicity profiling of pharmaceutical
and consumer chemicals
\citep{hammitzsch_cbp30_2015, omahony_discriminating_2018, simms_use_2021}
These 12 assay systems include models of autoimmune disease, chronic
(vascular) inflammation, allergy, monocyte activation, lung inflammation
and fibrosis, cardiovascular inflammation, and dermatitis, wound healing
\citep{kleinstreuer_phenotypic_2014, houck_evaluation_2023}.

Within the BioMAP panel, specific readouts for 3 different model assay
systems were identified as immunosuppression relevant for a
semi-quantitative flag of potential immunosuppression. Details of these
models were published previously
\citep{kleinstreuer_phenotypic_2014, houck_evaluation_2023}, including
an analysis of the results produced by four immunosuppressive drugs
\citep{houck_evaluation_2023}. The three model systems included in the
immunosuppression flag were:

1. the SAg system (T cell activation ``super-antigen'' model; intended
to model an autoimmune or chronic inflammation states relevant to T-cell
dependent conditions; uses co-cultured primary human peripheral blood
mononuclear cells {[}PBMC{]} and human umbilical vein endothelial cells
{[}HUVEC{]} stimulated with superantigens, i.e., T cell receptor
{[}TCR{]} antigens);

2. the BT system (T cell dependent B cell activation; intended to model
autoimmune, allergy, or asthma, or oncology disease states where B-cell
activation and antibody production are relevant; uses co-cultured PBMC
and CD19+-B cells stimulated with TCR antigens and anti-IgM); and,

3. the Mphg System (macrophage activation response; intended to model
chronic inflammation and macrophage activation relevant to conditions
involving cardiovascular inflammation, restenosis, and arthritis; uses
co-cultured HUVEC cells and macrophages stimulated using toll-like
receptor 2 {[}TLR2{]} ligands derived from yeast).

Endpoints from these systems considered immunosuppression relevant were
effects on PBMC viability in the SAg and BT systems; decreased B cell
proliferation in BT system; decreased T cell proliferation in the SAg
system; decreased soluble IgG production in the BT system; and decreased
IL-10 production in the Mphg systems.

The flags used here reflect selective immunosuppressive activity
\emph{in vitro} at the endpoints specified as
``immunosuppression-relevant,'' where selectivity is defined as
immunosuppression-relevant bioactivity occurring at concentrations lower
than those that elicit overt cytotoxicity. Cytotoxicity is determined
using sulforhodamine B (SRB), a total protein marker, to monitor for
significant loss of cellular protein (compared against historical
values) in the BioMAP systems. The LEC among the
immunosuppression-relevant endpoints was subtracted from the minimum LEC
among the SRB cell viability endpoints. If there were no chemical
effects on the SRB cell viability endpoints, the
immunosuppression-relevant LEC was subtracted from 3 (equivalent to 1000
M on a log10- M scale). Selectivity scores of less than 0.25 log10- M
were coded as low concern (``blue'') (i.e., no selective
immunosuppression-relevant bioactivity observed. Chemicals with
selectivity scores of greater than 0.25 were assigned the medium concern
flag (``yellow''). No chemicals were assigned the high concern flag for
this technology.

\hypertarget{in-vitro-toxicokinetics-tk}{%
\subsubsection{\texorpdfstring{\emph{In Vitro} Toxicokinetics
(TK)}{In Vitro Toxicokinetics (TK)}}\label{in-vitro-toxicokinetics-tk}}

Dosimetric conversion of NAM data to an administered equivalent dose
(AED) requires consideration of chemical TK in a process known as
\emph{in vitro-in vivo} extrapolation (IVIVE). As described previously
in Wetmore et al. \citep{wetmore_integration_2012}, a simplified
HT-IVIVE TK approach utilizes \emph{in vitro} experimental measures of
hepatic clearance and plasma protein binding to estimate internal blood
concentrations such as the steady-state concentration (Css).
Experimental hepatic clearance assays were conducted as previously
described \citep{wetmore_integration_2012} for all PFAS passing stock QC
evaluation. Individual PFAS were incubated with pooled adult human mixed
sex hepatocyte suspensions and monitored for substrate depletion (i.e.,
loss of parent PFAS) over a 240 minute time course
\citep{kreutz_category-based_2023, crizer2023vitro}. Assay reference
compounds were included to ensure hepatocytes were performing as
expected; and negative controls were included to monitor and correct for
abiotic loss where needed. Plasma protein binding was measured using
ultracentrifugation, deriving fraction unbound in plasma (fup) after
quantitating levels in the aqueous supernatant resulting after
ultracentrifugation and the amount present in the time-matched whole
plasma \citep{smeltz_plasma_2023, kreutz_category-based_2023}. In
addition to being used in HT-IVIVE to derive administered equivalent
dosages \citep{wetmore_incorporating_2015, paul_friedman_utility_2020},
these TK values can be evaluated to inform PFAS half-life estimations,
persistence and bioaccumulation in general.

TK flags that captured plasma protein binding, hepatic metabolic
stability and PFAS metabolite formation were developed based on
experimental findings and downstream analyses. These were binary in
structure: denoting presence and absence of a flag, respectively. The
three flags for `PlasBind' were underpinned by \emph{in vitro} fraction
unbound in plasma (fup) data (Smeltz et al., Kreutz et al.
\citep{smeltz_plasma_2023, kreutz_category-based_2023} -- plasma protein
binding that was higher than 50\% of non-PFAS chemicals (and 25\% of
tested PFAS) (fup \textless{} 0.11) would be denoted `High'; a `Higher'
flag would correspond to fup \textless{} 0.0109 which is higher than
50\% of tested PFAS; and `Highest' flag would correspond to fup
\textless{} 0.0039, higher than 75\% of tested PFAS. These 3 flags were
collapsed into a single TK Plasma Binding flag for consistency with the
other NAM flags as detailed in Table~\ref{tbl-nams}.

`Highest' flag was mapped to the `high confidence' flag, whereas
`Higher' was mapped to `moderate confidence' and `High' to `low
confidence'. The TK\_Metab designations, of which there were 3,
corresponded to measures of hepatic \emph{in vitro} clearance (Clint)
with `Stable' denoting a Clint = 0, `Slow' denoting a Clint less than
5.97 uL/min/million hepatocytes (observed for 75\% of PFAS); and `Rapid'
denoting a Clint greater than 5.97 uL/min/million hep
\citep{kreutz_category-based_2023, crizer2023vitro}). Again these were
mapped to `High', `Moderate' and `Low' as shown Table~\ref{tbl-nams} for
consistency with the other flags under a summary flag named `TK\_Metab'.
Finally, TK\_Struc\_Endo corresponds to a structural flag to identify
substances, due to their similarity to endogenous transporter ligands,
are more likely to act as a transporter substrate
\citep{dawson_machine_2023}. Substances presenting a structural flag
were mapped to the ``Moderate'' as shown in Table~\ref{tbl-nams}.

Quality control (qc) flags that leverage targeted analytical chemistry
evaluations that occurred during method development and TK data
generation are also included to provide quality metrics for the PFAS
stocks used during screening. In addition to the stock QC flag described
earlier, a qc\_httk flag is also included that notes significant abiotic
loss (i.e., \textgreater50\% loss of parent analyte within 60 minutes of
assay initiation in negative controls) within the hepatic metabolic
clearance assay. This observation may have implications for
interpretation of the NAM bioactivity data.

\hypertarget{sec-code}{%
\section{Data analysis software and code}\label{sec-code}}

Data processing was conducted using the Anaconda distribution of Python
3.9 and associated libraries. Jupyter Notebooks, scripts and datasets
will be made available on github at XXXX and on Figshare at XXXX.

\hypertarget{results-and-discussion}{%
\section{Results and discussion}\label{results-and-discussion}}

\hypertarget{primary-and-secondary-structural-categories}{%
\subsection{Primary and secondary structural
categories}\label{primary-and-secondary-structural-categories}}

The PFAS landscape following application of the TSCA SNUR rule to DSSTox
resulted in a dataset comprising 10,576 substances plus 3,126
degradation products for a total of 13,702.

Minimal structural overlap was found between the accessible training set
substances from the Catalogic model and the TSCA inventory substances.
Figure~\ref{fig-miti} depicts a t-SNE plot for the MITI training set
substances relative to the TSCA substances using Morgan chemical
fingerprints as inputs. In view of this, the degradation products
simulated (comprising 22\% of the landscape) should be interpreted with
caution until additional experimental data are collected and new models
developed.

Chain lengths could not be computed for four substances:
DTXSID901222929, DTXSID101138156, DTXSID301146476, DTXSID301336809 as
shown in Table~\ref{tbl-dropped}. Based on inspection and given the
presence of metal ions or mixtures, these four substances were dropped
from further consideration. Thus, the final PFAS landscape used for the
remainder of the analysis comprised 13,698 substances.

\hypertarget{tbl-dropped}{}
\begin{longtable}[]{@{}
  >{\raggedright\arraybackslash}p{(\columnwidth - 8\tabcolsep) * \real{0.1667}}
  >{\centering\arraybackslash}p{(\columnwidth - 8\tabcolsep) * \real{0.2083}}
  >{\centering\arraybackslash}p{(\columnwidth - 8\tabcolsep) * \real{0.2083}}
  >{\centering\arraybackslash}p{(\columnwidth - 8\tabcolsep) * \real{0.2083}}
  >{\centering\arraybackslash}p{(\columnwidth - 8\tabcolsep) * \real{0.2083}}@{}}
\caption{\label{tbl-dropped}Substances dropped due to lack of chain
length derivation.}\tabularnewline
\toprule\noalign{}
\begin{minipage}[b]{\linewidth}\raggedright
DTXSID
\end{minipage} & \begin{minipage}[b]{\linewidth}\centering
DTXSID901222929
\end{minipage} & \begin{minipage}[b]{\linewidth}\centering
DTXSID101138156
\end{minipage} & \begin{minipage}[b]{\linewidth}\centering
DTXSID301146476
\end{minipage} & \begin{minipage}[b]{\linewidth}\centering
DTXSID301336809
\end{minipage} \\
\midrule\noalign{}
\endfirsthead
\toprule\noalign{}
\begin{minipage}[b]{\linewidth}\raggedright
DTXSID
\end{minipage} & \begin{minipage}[b]{\linewidth}\centering
DTXSID901222929
\end{minipage} & \begin{minipage}[b]{\linewidth}\centering
DTXSID101138156
\end{minipage} & \begin{minipage}[b]{\linewidth}\centering
DTXSID301146476
\end{minipage} & \begin{minipage}[b]{\linewidth}\centering
DTXSID301336809
\end{minipage} \\
\midrule\noalign{}
\endhead
\bottomrule\noalign{}
\endlastfoot
CASRN & 64443-70-5 & 17631-69-5 & 885275-45-6 & 713512-19-7 \\
Structure &
\includegraphics[width=0.2\textwidth,height=\textheight]{DTXSID901222929.png}
&
\includegraphics[width=0.2\textwidth,height=\textheight]{DTXSID101138156.png}
&
\includegraphics[width=0.2\textwidth,height=\textheight]{DTXSID301146476.png}
&
\includegraphics[width=0.2\textwidth,height=\textheight]{DTXSID301336809.png} \\
\end{longtable}

There were also 26 substances that were tagged as ``Not PFAS'' based on
the OECD structure definitions used within PFAS-Map. Upon manual
inspection of the substances, DTXSID9096236 {[}CASRN 422-69-5{]},
DTXSID8063181 {[}CASRN 55364-35-7{]} and DTXSID5059872 {[}CASRN
354-83-6{]} were reassigned to the ``Silicon PFAS'' primary category.
Substances DTXSID1011943 {[}CASRN 1780277-75-9{]}, DTXSID3012966
{[}CASRN 28781-82-0{]}, DTXSID50448610 {[}CASRN 79035-75-9{]},
DTXSID8012466 {[}CASRN 590424-08-1{]} and DTXSID60667618 {[}CASRN
817562-60-0{]} were reassigned to the ``Side-chain aromatics'' primary
category. Substance WXGNWUVNYMJENI-UHFFFAOYSA-N was reassigned to the
``Other aliphatics'' primary category. The remainder were reassigned to
the ``PFAS derivatives'' primary category.
Figure~\ref{fig-secondary-cats} is a bar chart showing the number of
PFAS within each secondary category.

\begin{figure}

{\centering \includegraphics{nts_files/figure-pdf/fig-secondary-cats-output-1.pdf}

}

\caption{\label{fig-secondary-cats}Bar chart showing the number of
substances within each secondary category, ordered by primary category
root. Methods to define primary and secondary categories are outlined in
Sections 2.31 and 2.32. Lt7, chain length less than 7; gte7, chain
length greater than or equal to 7.}

\end{figure}

From Figure~\ref{fig-secondary-cats}, there appear to be no substances
assigned as ``Unable to open ring(s)''. In fact there were 5 substances
that were tagged as ``Unable to open ring(s)'', two of which included
heterocyclic moieties comprising a hydrazine linkage and a disulphide
bond and the remaining three were thiane/oxane like (see
Table~\ref{tbl-ring}).

\hypertarget{tbl-ring}{}
\begin{longtable}[]{@{}
  >{\centering\arraybackslash}p{(\columnwidth - 4\tabcolsep) * \real{0.3333}}
  >{\centering\arraybackslash}p{(\columnwidth - 4\tabcolsep) * \real{0.3333}}
  >{\centering\arraybackslash}p{(\columnwidth - 4\tabcolsep) * \real{0.3333}}@{}}
\caption{\label{tbl-ring}`Unable to open ring(s)'
substances.}\tabularnewline
\toprule\noalign{}
\begin{minipage}[b]{\linewidth}\centering
DTXSID0053124
\end{minipage} & \begin{minipage}[b]{\linewidth}\centering
DTXSID2051982
\end{minipage} & \begin{minipage}[b]{\linewidth}\centering
FAQDJDLEAALLIF-UHFFFAOYSA-N
\end{minipage} \\
\midrule\noalign{}
\endfirsthead
\toprule\noalign{}
\begin{minipage}[b]{\linewidth}\centering
DTXSID0053124
\end{minipage} & \begin{minipage}[b]{\linewidth}\centering
DTXSID2051982
\end{minipage} & \begin{minipage}[b]{\linewidth}\centering
FAQDJDLEAALLIF-UHFFFAOYSA-N
\end{minipage} \\
\midrule\noalign{}
\endhead
\bottomrule\noalign{}
\endlastfoot
\includegraphics[width=0.15\textwidth,height=\textheight]{open_ring_1a.png}
&
\includegraphics[width=0.15\textwidth,height=\textheight]{open_ring_2a.png}
&
\includegraphics[width=0.15\textwidth,height=\textheight]{open_ring_1.png} \\
FZRBYUVNWOOAJS-UHFFFAOYSA-N & MBHWADCTCXPAHT-UHFFFAOYSA-N & \\
\includegraphics[width=0.15\textwidth,height=\textheight]{open_ring_2.png}
&
\includegraphics[width=0.15\textwidth,height=\textheight]{open_ring_3.png}
& \\
\end{longtable}

Across the more than 13,000 PFAS substances evaluated, forty-three
percent of the substances fell into the ``Other aliphatics, lt7''
category. In addition, 667 substances fell into the ``Unclassified,
lt7'' or ``Unclassified, gte7'' secondary categories. This represents a
potential limitation of using broad definitions represented by the OECD
primary categories themselves. A chemotype ToxPrint enrichment was
explored following the approach outlined in Wang et
al.\citep{wang_high-throughput_2019} but using the PFAS specific
ToxPrints developed in Richard et al \citep{richard_new_2023} (see
Section~\ref{sec-supp} for methodological details). This was an effort
to identify whether there were specific structural features that might
be helpful in splitting apart those primary categories with the largest
memberships namely (i.e., ``Other aliphatics'' and ``Unclassified'').
The most enriched features for the ``Unclassified'' category included
fluorotelomer chains and phosphorus or sulfonic acid functional groups
whereas heteroatoms, nitriles, amines and epoxides featured as
functional groups for the ``Other aliphatics''. However, these enriched
features were not determined to be sufficiently distinctive to justify
creation of additional primary categories.

Structural similarity was evaluated within and between secondary
categories to determine which secondary categories required further
subcategorization (as discussed in Section~\ref{sec-objective-threshold}
of the Methods). Figure~\ref{fig-threshold} shows the two distributions
of the median pairwise distance distributions in the between and within
secondary category combinations. The objective distance threshold
derived by taking the 5th percentile of the median pairwise distances
from the between categories combinations resulted in a value of 0.75.

\begin{figure}

{\centering \includegraphics[width=0.5\textwidth,height=\textheight]{Figure2_200823.png}

}

\caption{\label{fig-threshold}Probability density functions of the
median Jaccard pairwise distance distributions for within (orange) and
between (blue) secondary categories. Orange and blue graphed lines
represent the fits to the probability density distributions.}

\end{figure}

Based on the threshold, 13 secondary categories
(Table~\ref{tbl-require-cat}) were found to exceed the value that would
render them subject to further subcategorization. The thirteen secondary
categories included the ``Other aliphatics'', ``Side-chain aromatics'',
``Silicon PFAS'', ``Unclassified'', ``PFAA precursors'' and ``Non-PFAA
perfluoroalkyls''. The ``Other aliphatics'' categories are of little
surprise given their membership sizes were the largest out of all the
secondary combinations; hence, these categories were expected to be the
most diverse in terms of their structural makeup. Since the ``Unable to
open ring(s)'' category only comprised 5 substances in total (as shown
in Table~\ref{tbl-ring}), this category was excluded from any
subcategorization.

\hypertarget{tbl-require-cat}{}
\begin{longtable}[]{@{}ll@{}}
\caption{\label{tbl-require-cat}List of secondary categories exceeding
the threshold and their corresponding median pairwise distances (rounded
to 2 decimal places)}\tabularnewline
\toprule\noalign{}
Primary-Secondary Categories & Median pairwise distance \\
\midrule\noalign{}
\endfirsthead
\toprule\noalign{}
Primary-Secondary Categories & Median pairwise distance \\
\midrule\noalign{}
\endhead
\bottomrule\noalign{}
\endlastfoot
Fluorotelomer PFAA precursors, lt7 & 0.79 \\
Non-PFAA perfluoroalkyls, lt7 & 0.85 \\
Other aliphatics, gte7 & 0.77 \\
Other aliphatics, 'lt7 & 0.88 \\
PFAA precursors, lt7 & 0.83 \\
PFAAs, lt7 & 0.8 \\
PFAS derivatives, lt7 & 0.82 \\
Side-chain aromatics, gte7 & 0.79 \\
Side-chain aromatics, lt7 & 0.88 \\
Silicon PFAS, lt7 & 0.83 \\
Unable to open ring(s), lt7 & 0.9 \\
Unclassified, gte7 & 0.76 \\
Unclassified, lt7 & 0.87 \\
\end{longtable}

Figure~\ref{fig-tertcat} shows the membership following the first
generation of clusters being created for the 12 secondary categories
that exceeded this objective threshold.

\begin{figure}

{\centering \includegraphics{nts_files/figure-pdf/fig-tertcat-output-1.pdf}

}

\caption{\label{fig-tertcat}Bar chart showing the number of substances
within each tertiary category, ordered by primary and secondary category
roots. Methods to define tertiary categories are outlined in Section
2.7. Lt7, chain length less than 7; gte7, chain length greater than or
equal to 7.}

\end{figure}

Following creation of the next generation categories, there were 18
tertiary categories that met or exceeded the threshold and were
subcategorized further. The root primary categories were predominantly
from the ``Other aliphatics'', ``Side-chain aromatics'', ``Fluorotelomer
PFAA precursor'' and ``Non-PFAA perfluoroalkyls'' categories.
Figure~\ref{fig-quartcat} reflects the quaternary categories for the 18
that were subset further.

\begin{figure}

{\centering \includegraphics{nts_files/figure-pdf/fig-quartcat-output-1.pdf}

}

\caption{\label{fig-quartcat}Bar chart showing the number of substances
within each quaternary category, ordered by primary, secondary, and
tertiary category roots. Methods to define quaternary categories are
outlined in Section 2.7. Lt7, chain length less than 7; gte7, chain
length greater than or equal to 7.}

\end{figure}

Terminal categories were defined as either secondary or tertiary
categories that did not exceed the threshold, as well as all quaternary
categories. A total of 85 terminal categories were ultimately derived.
This represented a trade-off in terms of the final number of terminal
categories that was a practical number to characterize the landscape of
PFAS balanced with maximizing structural similarity within the
categories themselves. The full list of 13,768 substances together with
their terminal category assignments are provided in the supplementary
information. Structural similarity within categories did increase
following subcategorization, Figure~\ref{fig-ecdfs-left} shows the ECDFs
of several terminal categories which are left shifted relative to the
original ECDFs for the secondary categories
(Figure~\ref{fig-ecdfs-within}), i.e.~the pairwise distance range
decreases.

\hypertarget{sec-maxmin-all}{%
\subsection{Selection of representative
substances}\label{sec-maxmin-all}}

Whilst centroids were selected as the most representative substance from
each terminal category, there was a recognition that a single chemical
was unlikely to capture the breadth of diversity within a category.
Additional substances to capture the breadth and structural diversity
relied on the MaxMinPicker method. This method was used to select up to
3 further substances in addition to the centroid. A total of 320
substances were selected using this approach for 80 of the terminal
categories. Terminal categories with 5 or fewer members did not result
in any additional substances being selected (beyond the centroid) by the
approach. Table~\ref{tbl-maxmin-cat} lists the 5 terminal categories
which had insufficient membership to apply the MaxMinPicker approach.

\hypertarget{tbl-maxmin-cat}{}
\begin{longtable}[]{@{}ll@{}}
\caption{\label{tbl-maxmin-cat}Terminal categories for which the MaxMin
approach was not undertaken.}\tabularnewline
\toprule\noalign{}
Terminal category & Membership \\
\midrule\noalign{}
\endfirsthead
\toprule\noalign{}
Terminal category & Membership \\
\midrule\noalign{}
\endhead
\bottomrule\noalign{}
\endlastfoot
PFAA precursors, lt7, 1, 2 & 4 \\
PFAA precursors, lt7, 1, 3 & 5 \\
Unable to open ring(s), lt7 & 4 \\
Unable to open ring(s), gte7 & 1 \\
Unclassified, gte7, 2, 1 & 5 \\
\end{longtable}

To evaluate the proportion of structural diversity captured by the
selected representative substances, the normalized cumulative minimum
distance was calculated as a function of the number of substances
selected using the MaxMinPicker method as discussed in
Section~\ref{sec-maxmin} . There were 11 terminal categories, out of the
80 terminal categories for which diverse substances were selected, where
picking 3 substances captured 50\% of the structural diversity (shown in
Table~\ref{tbl-structdiversity-all}).

\hypertarget{tbl-structdiversity-all}{}
\begin{longtable}[]{@{}
  >{\raggedright\arraybackslash}p{(\columnwidth - 6\tabcolsep) * \real{0.2466}}
  >{\raggedright\arraybackslash}p{(\columnwidth - 6\tabcolsep) * \real{0.2603}}
  >{\raggedright\arraybackslash}p{(\columnwidth - 6\tabcolsep) * \real{0.2466}}
  >{\raggedright\arraybackslash}p{(\columnwidth - 6\tabcolsep) * \real{0.2466}}@{}}
\caption{\label{tbl-structdiversity-all}Terminal categories for which 3
representative substance selections capture more than 50\% of the
structural diversity.}\tabularnewline
\toprule\noalign{}
\begin{minipage}[b]{\linewidth}\raggedright
Terminal category
\end{minipage} & \begin{minipage}[b]{\linewidth}\raggedright
Number of chemicals for 80\% structural diversity
\end{minipage} & \begin{minipage}[b]{\linewidth}\raggedright
Cumulative \% of Structural Diversity
\end{minipage} & \begin{minipage}[b]{\linewidth}\raggedright
Terminal Category size
\end{minipage} \\
\midrule\noalign{}
\endfirsthead
\toprule\noalign{}
\begin{minipage}[b]{\linewidth}\raggedright
Terminal category
\end{minipage} & \begin{minipage}[b]{\linewidth}\raggedright
Number of chemicals for 80\% structural diversity
\end{minipage} & \begin{minipage}[b]{\linewidth}\raggedright
Cumulative \% of Structural Diversity
\end{minipage} & \begin{minipage}[b]{\linewidth}\raggedright
Terminal Category size
\end{minipage} \\
\midrule\noalign{}
\endhead
\bottomrule\noalign{}
\endlastfoot
Unclassified, gte7, 2.0, 3.0 & 1 & 100 & 9 \\
Unclassified, lt7, 2.0, 1.0 & 3 & 92.63 & 7 \\
PFAA precursors, lt7, 1.0, 1.0 & 3 & 85.29 & 7 \\
PFAS derivatives, lt7, 3.0, 2.0 & 3 & 84.32 & 6 \\
Unclassified, gte7, 2.0, 4.0 & 3 & 80.87 & 12 \\
Non-PFAA perfluoroalkyls, lt7, 2.0, 2.0 & 4 & 70.63 & 15 \\
PFAA precursors, gte7, nan, nan & 5 & 68.59 & 58 \\
Fluorotelomer PFAA precursors, lt7, 3.0, 2.0 & 5 & 64.18 & 15 \\
Fluorotelomer PFAA precursors, lt7, 3.0, 1.0 & 6 & 58.96 & 18 \\
PFAA precursors, lt7, 3.0, nan & 6 & 54.08 & 18 \\
Non-PFAA perfluoroalkyls, gte7, nan, nan & 5 & 52.83 & 48 \\
\end{longtable}

Notes: Column 1 represents the number of substances that would be
required to capture 80\% of the structural diversity in the category,
Cumulative \% of Structural Diversity represents the normalized
cumulative minimum distance for up to 3 selected diverse substances.
Note the 80\% used as a threshold is purely for demonstration purposes
only.

For the largest terminal category, ``Other aliphatics, lt7, 3,3'', the
existing up to 3 diverse substances only captures 0.46\% of the
structural diversity. In order to capture 80\% of the structural
diversity for this terminal category, 935 substances would need to be
selected for additional testing and assessment. The number of substances
to select from each terminal category to capture 80\% of the structural
diversity varied from 1 (as shown above in
Table~\ref{tbl-structdiversity-all}) to 935 with the median number being
20.

Figure~\ref{fig-structdiv} shows the curves of the number of diverse
selections as a function of the percentage normalized cumulative minimum
distances for 10 terminal categories. These vary in steepness showing
how quickly or not the structural diversity coverage converges with
number of diverse selections depending on the terminal category of
interest.

\begin{figure}

{\centering \includegraphics{Figure1_structural_diversity.png}

}

\caption{\label{fig-structdiv}For a selection of terminal categories,
the extent to which 100\% structural diversity is captured relative to
number of diverse chemicals selected varies.}

\end{figure}

Figure~\ref{fig-structdiv-corr} attempts to summarize the tradeoff of
the number of diverse chemicals (centroids and MaxMin) as a function of
\% structural diversity captured on a per terminal category basis.

\begin{figure}

{\centering \includegraphics{Terminal categorisation for full Landscape.png}

}

\caption{\label{fig-structdiv-corr}Lineplot showing the number of
diverse substances that would need to be selected to achieve a specific
\% structural diversity coverage across each terminal category.}

\end{figure}

The diverse selections identified earlier for the terminal categories
reflects a pragmatism in terms of identifying a potential candidate list
of substances. As discussed in later Section~\ref{sec-tsca}, the
structural diversity captured forms one of the considerations in test
candidate selection relative to those terminal categories that are data
poor or contain substances that are on the TSCA inventory.

\hypertarget{evaluation-of-physchem-consistency-within-terminal-categories}{%
\subsection{Evaluation of physchem consistency within terminal
categories}\label{evaluation-of-physchem-consistency-within-terminal-categories}}

For the 13,449 substances in the PFAS landscape for which OPERA
predictions could be generated, 66 substances (0.5\%) could not be
assigned into any specific physchem testing track, 79 substances (0.6\%)
were assigned into testing track D, the remainder were relatively evenly
distributed amongst testing tracks A-C (range: 3649-5277, 27-39\%). The
proportions were similar if only substances on the TSCA active inventory
were considered namely testing track A (24\%), testing track B (28\%),
testing track C (41\%), testing track D (6\%) and no testing track
(2\%). Across the terminal categories, there was a general trend of
number of testing tracks increasing with size in category membership
(see Figure~\ref{fig-cat-mem}). Figure~\ref{fig-tsne-physchem} shows an
example of one of the most diverse and largest terminal categories
``Other aliphatics, lt7, 3, 3'' which comprises 2232 members and spans
all 4 testing tracks. Although substances predominantly lie within the
testing track B, there is no discernible separation between the tracks
across the structural category as characterized by Morgan fingerprints.
In contrast all 92 substances belonging to terminal category ``FASA
based PFAA precursors, gte7, nan, nan'' fell into testing track A
(figure not shown) whereas the 44 substances in ``PFAAs, lt7, 1, nan''
fell into testing tracks A and B, with the majority of substances in
testing track B. Those substances in testing track A all have estimated
water solubility values over a magnitude lower (data not shown). There
was a positive association between how structurally diverse a terminal
category was and the consistency in physchem profile observed (as
reflected by the physchem testing tracks). However the Morgan
fingerprints could not resolve the differences. PFAS ToxPrint
fingerprints were also explored to evaluate the extent to which they had
greater resolution in differentiate features that would account for the
differences in physchem profile (results not presented). For the
selection of potential candidates for tiered testing, the physchem
profile remains an important consideration in concert with the
structural diversity described in Section~\ref{sec-maxmin-all}.

\begin{figure}

{\centering \includegraphics{Figure9_220823.png}

}

\caption{\label{fig-tsne-physchem}t-SNE projections for terminal
category a) ``Other aliphatics, lt7, 3, 3'' and b) t-SNE projection for
terminal category ``PFAAs', `lt7', 1.0, nan'' using Morgan chemical
fingerprints with testing tracks A-D overlaid.}

\end{figure}

\hypertarget{variation-of-pod-values-across-and-within-terminal-categories}{%
\subsection{Variation of POD values across and within terminal
categories}\label{variation-of-pod-values-across-and-within-terminal-categories}}

Ultimately, the terminal categories are intended to facilitate a
read-across. To explore the feasibility of this further, the 10th
percentile values of minimum oral and inhalation study level PODs were
derived using available data for 71 substances and 15 substances
respectively. The distributions were plotted in a series of box plots.
\emph{In vivo} toxicity data were available for at least one chemical in
28 of the 85 terminal categories across the 2 routes of exposure. The
available data allowed preliminary trends for terminal categories to be
observed where the primary root was FASA based PFAA precursors, PFAAs,
Fluorotelomer PFAA precursors, and some of the Other aliphatics
categories. In Figure~\ref{fig-pods-all}, boxplots for each of the
routes of exposure are shown side by side though there were only 8
terminal categories (``Fluorotelomer PFAA precursors, lt7, 2, 2'',
``Fluorotelomer PFAA precursors, lt7, 3, 3'', ``Non-PFAA
perfluoroalkyls, lt7, 2,3'', ``Other aliphatics, lt7, 1, 3'', ``Other
aliphatics, lt7, 2, 2'', ``Other aliphatics, lt7, 3, 3'', ``PFAAs, gte7,
nan, nan'', ``PFAS derivatives, lt7, 2, nan'') for which inhalation data
was available.

\begin{figure}

{\centering \includegraphics{Figure11_inhalation_oral_PODs.png}

}

\caption{\label{fig-pods-all}Boxplots of the variation of 10th
percentiles of minimum point of departure values from oral and
inhalation studies (units mg/kg/day). The box in the boxplot reflects
the quartiles of the dataset, whilst the whiskers extend to + 1.5 *
inter-quartile range (IQR). Outliers are shown as points if they exceed
1.5 * IQR. The inhalation boxplot is shown \ul{below} the oral boxplot
for a given terminal category.}

\end{figure}

Figure~\ref{fig-pods-oral} shows boxplot and strip plots for the oral
studies only. It appears that substances at each end of the spectrum of
chain length within a category tended to exhibit lower toxicity, i.e.,
their aggregate POD is higher. The spread of POD values within a
category with greater diversity in chain length tend to span
\textgreater{} 2 orders of magnitude. Moreover, of the 71 substances
with studies, 29 were associated with NOEL/NOAEL values only or a
combination of NOEL/NOAEL/LOEL/LOAEL values.

\begin{figure}

{\centering \includegraphics{ch7_POD_S1_oral_220823.png}

}

\caption{\label{fig-pods-oral}Boxplots showing the spread of the 10th
percentile of the minimum oral POD values across and within terminal
categories bounded by the carbon chain number. The box in the boxplot
reflects the quartiles of the dataset, whilst the whiskers extend to +
1.5 * inter-quartile range (IQR). Outliers are shown as points if they
exceed 1.5 * IQR.}

\end{figure}

Although the available toxicity data are limited, there does appear to
be some separation in the potency distributions between terminal
categories based on a common primary root. Inspection of
Figure~\ref{fig-pods-oral} does show a shift in potency values between
the 2 FASA based PFAA precursors categories with those in the gte7
category being more potent. Similarly, there is a general shift between
the PFAA categories with a left shift for those substances in the gte7
category vs the majority of the PFAA lt7 categories. However, the
relatively large spread for some of the terminal categories suggests
that additional refinement beyond structural similarity and chain length
will likely be needed for some terminal categories prior to broader
application in a read-across context.

\hypertarget{qualitative-nam-flags}{%
\subsection{Qualitative NAM flags}\label{qualitative-nam-flags}}

There were six data streams with qualitative flags assigned for the
\textasciitilde150 PFAS tested as part of the research project described
in Patlewicz et al \citep{patlewicz_towards_2022} namely: 1) nuclear
receptor assays (NR); 2) developmental toxicity (zebrafish testing); 3)
DNT (developmental neurotoxicity); 4) thyroid toxicity; 5)
immunosuppression (BioMAP assays); and 6) toxicokinetics (TK). No data
were represented as null values (white colored), data available but no
flag identified as denoted a 0 (blue colored), 1 denoted a medium
confidence flag (yellow colored) and 2 was associated with a high
confidence flag (colored in red) consistent with the descriptions
described in Table~\ref{tbl-nams}. Figure~\ref{fig-nams} profiles all
the NAM flags across the different technologies together with a stock QC
flag {[}\citet{smeltz_targeted_2023}{]} (Pass (red)) and a qc\_httk flag
(Pass (red)).

\begin{figure}

{\centering \includegraphics{NAM_flags_200823.png}

}

\caption{\label{fig-nams}Heatmap of NAMs flags for the
\textasciitilde150 PFAS substances (\textasciitilde120 of which passed
analytical QC) tested as part of the research programme described in
Patlewicz et al \citep{patlewicz_towards_2022}}

\end{figure}

From Figure~\ref{fig-nams}, the first two columns represent the quality
control (QC) information. The next 5 columns represent the NR data. The
next 2 columns represent the developmental toxicity (ZF) assay and the
DNT assay. The next 8 columns represent the thyroid assay outcomes
followed by the integrated immunotoxicity flag from the BioMap assays.
The last 3 columns represent the TK flags.

Of the 127 substances with associated NAM and TK flags, 124 matched with
a substance in the PFAS landscape, permitting a closer examination of
how consistent and concordant the NAM flags were within and across 26 of
the 85 PFAS terminal categories (Figure~\ref{fig-nams-hm}). For 9 of the
terminal categories that had at least 5 or more substances tested across
the NAM assays, an enrichment analysis (using a Fischer exact test) was
performed to identify whether any category was enriched for any flags.
Terminal category ``PFAAs, gte7'' was enriched for the nuclear receptor
PXR assay whereas ``Other aliphatics, gte7, 2, nan'' and ``Fluorotelomer
PFAA precursors, gte7'' were enriched for immunosuppression. As an
illustrative example, Figure~\ref{fig-nams-struct} shows 2 contrasting
terminal categories and their corresponding NAM profiles and the degree
to which these were consistent across the category members.

\begin{figure}

{\centering \includegraphics{Figure 12_220823.png}

}

\caption{\label{fig-nams-struct}Heatmap for 2 of the terminal structural
categories to illustrate the extent of their concordance across NAM
profiles}

\end{figure}

These heatmaps might also play a role in probing to what extent the NAM
profiles are able to rationalize the differences in POD values observed
for specific terminal categories. As an example, the terminal category
``PFAAs, gte7'' was associated with a large variation in 10th percentile
POD values as shown in Figure~\ref{fig-pods-oral}.
Figure~\ref{fig-nams-pod} shows both the NAM profiles, chain length and
POD information side by side for this category for convenience. Category
members with chain lengths of 7 tended to give rise to responses for
nuclear receptors ESR and PPAR, whereas PXR was activated for members
with a chain length of 8. Immune responses were only observed for chain
lengths of 7. None of the members gave rise to any activity in the suite
of thyroid assays. TK flags showed that plasma binding was highest for
substances with a chain length of 7 but intrinsic clearance was largely
stable across the category. The most potent substances by \emph{in vivo}
toxicity were substances with a chain length of 8.

\begin{figure}

{\centering \includegraphics{NAMs_pod_200823.png}

}

\caption{\label{fig-nams-pod}Heatmap of showing the log of the 10th
percentile of the minimum oral POD values for terminal category ``PFAAs,
gte7'' and its associated NAM data.}

\end{figure}

Although the NAM data is limited, the insights gleaned are useful to
probe to what extent a terminal category might need to be subdivided
further or whether for a candidate substance for testing, the closest
neighbor by NAM profile might provide a targeted roadmap to identify the
most strategic tiered testing to undertake.

\hypertarget{sec-tsca}{%
\subsection{Potential regulatory application to support the National
Testing Strategy (NTS)}\label{sec-tsca}}

There are several considerations that come into play when identifying
potential candidates for tiered testing in concert with the landscape
defined. To make the NTS actionable, one consideration was to limit the
landscape to one that was constrained by the TSCA active inventory to
increase the feasibility of being able to identify a
manufacturer/importer of the substance. A second enables the tradeoff
between the number of diverse substances to select vs capturing the
structural diversity to be more practically addressed. Herein the scope
of terminal categories represented by the TSCA and TSCA active inventory
and the impact this has in terms of capturing structural diversity was
evaluated. Finally a proposal was outlined that considers how the
terminal categories could be triaged to initially focus on terminal
categories which were either data poor or contained members that
represented large exposure sources.

\hypertarget{constraining-the-landscape-to-the-tsca-active-inventory}{%
\subsubsection{Constraining the landscape to the TSCA active
inventory}\label{constraining-the-landscape-to-the-tsca-active-inventory}}

\hypertarget{tsca-inventory}{%
\paragraph{TSCA inventory}\label{tsca-inventory}}

Of the substances in the PFAS Landscape, only 617 substances were
identified to be on the TSCA inventory, of which 293 were `active' and
the remaining 324 `inactive'. Active and inactive refers to the EPA's
designation of whether a substance is active in US commerce based on the
rule requiring industry to report chemicals manufactured or imported or
processed in the US over a 10 year period ending 21st June 2016.
Figure~\ref{fig-barplot-tsca} shows a bar chart of the membership of the
terminal categories and how that differs when considering TSCA inventory
status (overall or by active TSCA only).

\begin{figure}

{\centering \includegraphics{Figure8_barchart_TSCA.png}

}

\caption{\label{fig-barplot-tsca}Bar chart showing membership of
terminal categories and how that differs when constrained by TSCA
inventory or TSCA active inventory.}

\end{figure}

The largest membership when constrained by presence on the TSCA
inventory still reflects the ``Other aliphatics, lt7'' and ``Other
aliphatics, gte7'' categories. Across the terminal categories, 75\% of
the categories (64 out of the 85 categories) contain members on the TSCA
inventory. If only categories containing substances that are on the TSCA
active inventory are considered, then the number of terminal categories
decreases to 53, i.e., 62\% coverage. The majority of the categories
where there are no examples on the TSCA inventory are relatively small
in size with fewer than 40 members. There were a couple of ``Side-chain
aromatics'' categories which were larger with members between 57-346 as
well as the two of the ``Unclassified'' categories with 52-97 members.

\hypertarget{sec-maxmin-tsca}{%
\paragraph{Selection of representative substances in the constrained
TSCA active inventory}\label{sec-maxmin-tsca}}

Centroids were computed for the 53 terminal categories containing
substances that were on the active TSCA inventory. For 14 of these
terminal categories, membership exceeded 5, which permitted the
MaxMinPicker approach to be applied to identified further analogues. An
additional 56 analogues were selected from this constrained landscape.
Figure~\ref{fig-venn} shows the overlap in substances (centroids and
diverse) across the unconstrained and the TSCA active constrained
landscapes. The minimal overlap between the sets highlights the
limitations of using a constrained inventory, i.e., one which does not
represent the breadth of the PFAS chemistry. However, the substances on
the TSCA active inventory represent those substances that are currently
in commerce in the US and potentially represent the largest exposure
source.

\begin{figure}

{\centering \includegraphics{Figure7_220823.png}

}

\caption{\label{fig-venn}Venn diagram showing the overlap in substances
based on whether they were identified as additional diverse picks or
centroids in the PFAS landscape and that constrained by the TSCA active
inventory.}

\end{figure}

An evaluation of the structural diversity captured using the centroids
and additional MaxMin substances relative to the number of substances
that would need to be selected to attain 80\% structural diversity
coverage was also undertaken in the same manner as had been performed
for the full landscape. For the 11 of the 14 categories where the MaxMin
approach had been applied, the diverse picks originally selected
captured more than 50\% of the structural diversity as shown in
Table~\ref{tbl-tsca-maxmin}. This is not so surprising given the TSCA
active set substantially limited the terminal category size and in turn
their diversity.

\hypertarget{tbl-tsca-maxmin}{}
\begin{longtable}[]{@{}
  >{\raggedright\arraybackslash}p{(\columnwidth - 6\tabcolsep) * \real{0.2466}}
  >{\raggedright\arraybackslash}p{(\columnwidth - 6\tabcolsep) * \real{0.2603}}
  >{\raggedright\arraybackslash}p{(\columnwidth - 6\tabcolsep) * \real{0.2466}}
  >{\raggedright\arraybackslash}p{(\columnwidth - 6\tabcolsep) * \real{0.2466}}@{}}
\caption{\label{tbl-tsca-maxmin}Constrained terminal categories where
the MaxMin approach had been applied. Terminal categories for which 3
representative substance selections capture more than 50\% of the
structural diversity}\tabularnewline
\toprule\noalign{}
\begin{minipage}[b]{\linewidth}\raggedright
Terminal category
\end{minipage} & \begin{minipage}[b]{\linewidth}\raggedright
Number of chemicals for 80\% structural diversity
\end{minipage} & \begin{minipage}[b]{\linewidth}\raggedright
Cumulative \% of Structural Diversity
\end{minipage} & \begin{minipage}[b]{\linewidth}\raggedright
Terminal Category size
\end{minipage} \\
\midrule\noalign{}
\endfirsthead
\toprule\noalign{}
\begin{minipage}[b]{\linewidth}\raggedright
Terminal category
\end{minipage} & \begin{minipage}[b]{\linewidth}\raggedright
Number of chemicals for 80\% structural diversity
\end{minipage} & \begin{minipage}[b]{\linewidth}\raggedright
Cumulative \% of Structural Diversity
\end{minipage} & \begin{minipage}[b]{\linewidth}\raggedright
Terminal Category size
\end{minipage} \\
\midrule\noalign{}
\endhead
\bottomrule\noalign{}
\endlastfoot
FASA based PFAA precursors, gte7, nan, nan & 6 & 57.63 & 16 \\
FASA based PFAA precursors, lt7, nan, nan & 4 & 69.04 & 12 \\
Fluorotelomer PFAA precursors, gte7, nan, nan & 3 & 87.81 & 20 \\
Fluorotelomer PFAA precursors, lt7, 2.0, 2.0 & 3 & 86.86 & 6 \\
Other aliphatics, gte7, 1.0, nan & 2 & 100 & 6 \\
Other aliphatics, lt7, 2.0, 1.0 & 6 & 55.54 & 13 \\
Other aliphatics, lt7, 3.0, 1.0 & 4 & 77.95 & 10 \\
PFAA precursors, gte7, nan, nan & 2 & 100 & 10 \\
PFAAs, gte7, nan, nan & 3 & 86.12 & 20 \\
PFAAs, lt7, 2.0, nan & 5 & 66.64 & 11 \\
PFAAs, lt7, 4.0, 2.0 & 4 & 75.7 & 9 \\
\end{longtable}

Notes: Number of chemicals for 80\% structural diversity represents the
number of diverse selections to capture 80\% of the structural
diversity, Cumulative \% of Structural Diversity reflects the structural
diversity captured by the diverse selections already made and Terminal
Category size reflects the size of the terminal category if constrained
by the availability of TSCA active substances.

For the largest terminal category, ``Other aliphatics, lt7, 3.0, 3.0'',
3 diverse substance selections only captured 19.85\% of the structural
diversity. In order to capture 80\% of the structural diversity for this
terminal category, 18 substances would need to be selected for
additional tiered testing. The number of substances to select from each
terminal category to capture 80\% of the structural diversity varied
from 2 to 18 with the median number being 4. Across the entire TSCA
active space, considering the 14 categories where a MaxMin approach
could be applied -- 74 substances would need to be selected capture an
80\% structural diversity. That it is to say, in order to capture up to
a 80\% coverage across all the TSCA active categories, at least 115
substances (centroids + MaxMin) would be ideally selected for testing.
Figure~\ref{fig-structdiv-tsca} summarizes the structural diversity
attained across all TSCA Active terminal categories.

\begin{figure}

{\centering \includegraphics{Terminal categorisation for TSCA Active Landscape.png}

}

\caption{\label{fig-structdiv-tsca}Lineplot of the TSCA active
constrained terminal categories as a function of number of diverse
substances selected and the \% structural diversity captured.}

\end{figure}

\hypertarget{proof-of-concept-workflow-identifying-potential-testing-candidates}{%
\subsubsection{Proof of Concept Workflow: Identifying potential testing
candidates}\label{proof-of-concept-workflow-identifying-potential-testing-candidates}}

The availability of toxicity data across different study types and the
presence of substances within different monitoring lists was arrayed
across the terminal categories. All oral and inhalation studies from
ToxValDB 9.4 were first retrieved as described in Section~\ref{sec-rax}.
There were 80 substances with data for one or more of the study types
which were then matched on the basis of DTXSID with substances in the
PFAS landscape. The resulting table was then transformed to produce a
table where columns represented different study types, rows were
substances and cells were labelled 1 if data for a specific study type
existed for a specific substance and 0 if no data existed. The
qualitative lists described in Section 2.1 were compiled together and
transformed into a table where rows represented substances, columns
represented the different list sources and cells were populated with a 1
or 0 to denote presence or absence on a specific list. There were 348
unique substances found across the different environmental monitoring
and discharge lists which were then matched with substances in the PFAS
landscape. CDR status tags and Pubmed count tags were then added to the
PFAS landscape. Columns representing the toxicity study types and
various lists were grouped by terminal category to produce a new table
which reflected presence or absence of information (denoted by 1 or 0)
on a per terminal category. Study quality was not considered - only the
availability of publicly available toxicity data. The set of terminal
categories were filtered to retain only those terminal categories which
contained members on the TSCA active inventory (53 terminal categories).
Figure~\ref{fig-hm-tscaact} provides a perspective of this information,
namely the toxicity data sparsity across the categories that fall within
the scope of the TSCA active inventory as well as different
environmental monitoring efforts or discussed in the literature. The
PFAAs categories and their subcategorizations show up with data entries
which is largely unsurprisingly, given the extent to which PFOA and PFOS
have been studied.

\begin{figure}

{\centering \includegraphics{Figure15_220823.png}

}

\caption{\label{fig-hm-tscaact}Heatmap of toxicity data availability and
different environmental monitoring efforts nationwide}

\end{figure}

Notes: \#Pubmed is a tag to denote presence or absence of articles
indexed in Pubmed. PROD-Data = Production data, DISCHARGE = Discharge
Monitoring data, DRINKING\_WATER = Drinking Water (State) Data,
DRINKING\_WATER-UCMR = Drinking Water data comprising Unregulated
Contaminant Monitoring Rule data and State level monitoring data,
TRI\_Waste = Toxics Release Inventory (TRI) Data Waste Managed,
TRI\_On-Site = On Site TRI Data, TRI\_Off-Site = Off Site TRI Data,
Analytical\_Mthds = PFAS with Validated Analytical Methods 533 and 537

Each of the earlier sections in of themselves highlight different lines
of evidence that can inform the identification of potential test
candidates. Here, an attempt was made to demonstrate how these steps can
be integrated together to triage terminal categories and their potential
candidates for subsequent tiered testing efforts
(Figure~\ref{fig-test-cand}). Step 1 is to consider a given terminal
category and determine whether it meets the condition of being a `data
poor category'. Data-poor in this context was to consider whether this
was a category that did not contain any members for which repeated dose
toxicity data existed (by the oral or inhalation route and with a
reported NOAEL, LOAEL, LOEL, NOEL, NEL or LEL value). There were 56
terminal categories out of the 85 total number of categories that met
this condition.

The next step was to focus on terminal categories that overlapped with
those which contained substances that were on the TSCA inventory.

\begin{figure}

{\centering \includegraphics{Figure15_PFAS.drawio.png}

}

\caption{\label{fig-test-cand}Workflow to highlight the main steps
involved in prioritizing potential test candidate(s) selection for a
given terminal category. If the Pubmed article availability was taken
into account, 30 categories would overlap with the TSCA data poor
categories or 23 of the TSCA active data poor categories.}

\end{figure}

There were 64 terminal categories that contained substances that were on
the TSCA inventory of which 53 terminal categories contained substances
that were on the TSCA active inventory. Of the TSCA categories, 37 also
satisfied the condition of being a `data poor' category, in contrast 27
of the TSCA active categories were `data poor'. The following step was
to consider terminal categories that contained substances that were on
different environmental monitoring lists. There were 42 terminal
categories that contained substances that were on one or more monitoring
lists or 68 if Pubmed article availability was taken into account. Of
these 42 terminal categories, 18 were also overlapping with data poor
TSCA categories or 16 of the data poor TSCA active categories. The 16
terminal categories included ``Other aliphatics, gte7, 1.0, nan'',
``Other aliphatics, lt7, 1.0, 1.0'', ``PFAA precursors, gte7, nan,
nan'', ``PFAA precursors, lt7, 2.0, nan'', ``PFAA precursors, lt7, 4.0,
nan'', ``PFAS derivatives, lt7, 1.0, 1.0'', ``PFAS derivatives, lt7,
1.0, 2.0'', ``PFAS derivatives, lt7, 3.0, 1.0'', ``Side-chain aromatics,
gte7, 1.0, 2.0'' and ``Unclassified, lt7, 3.0, nan''.

For a category that satisfied all these conditions, the next step would
be identify the representative substances characterizing the category
(namely the centroid and MaxMin substances and check whether any were on
the TSCA inventory). If none of these were on the inventory, then the
next step would be to check whether the next closest match to the
centroid was on the inventory. If not, the next steps would be to
identify the centroid and MaxMin substances from either the TSCA
constrained inventory or the TSCA active constrained inventory for that
terminal category. Figure~\ref{fig-test-cand} summarizes these steps in
a conceptual workflow.

For illustrative purposes, terminal category ``PFAA precursors, lt7,
2.0, nan'' was identified that met the conditions of being a data poor
category, containing members on the TSCA active inventory and containing
members on various environmental monitoring lists. This terminal
category comprises 22 members. The centroid, DTXSID60447694 was not on
the TSCA inventory. Alternatively, the TSCA active centroid
DTXSID0059877 {[}CASRN 355-38-4{]} could have been selected.
Figure~\ref{fig-case-study} shows a t-SNE project with the centroid,
MaxMin and TSCA centroid substances shown for illustrative purposes to
highlight their relative positions in the structural space captured
within the terminal category.

\begin{figure}[H]

{\centering \includegraphics{Figure15_case_study_220823.png}

}

\caption{\label{fig-case-study}t-SNE projection of terminal category
``PFAA precursors, lt7, 2, nan'' with its (TSCA active) centroid and
MaxMin substances shown.}

\end{figure}

Whilst only 39\% of the structural diversity is captured by the centroid
and additional MaxMin substances, this increases to 66\% if the
constrained inventory is considered.

\hypertarget{conclusions}{%
\section{Conclusions}\label{conclusions}}

EPA was directed by Congress to develop a process for prioritizing which
PFAS or classes of PFAS should be subject to additional research efforts
based on potential for human exposure to, toxicity of, and other
available information. Herein, we describe an approach to create a
relevant PFAS Landscape using the TSCA SNUR rule definition to continue
the efforts initiated in the National Testing Strategy. A landscape of
13,702 substances was created which comprised 10,576 substances in
conjunction with simulated degradation products of TSCA relevant
substances using the Catalogic expert system. Adding simulated
degradates was intended to enrich the landscape by substances that might
be expected to be found in the environment from existing substances in
commerce. The simulated degradation products were derived from an expert
system which includes training set substances that are PFAS though a
full characterization of the model relative to the PFAS landscape was
not feasible as some of the training set was proprietary in nature. For
the portion of training set substances that could be evaluated -- there
was a minimal overlap in datasets as shown in Figure~\ref{fig-miti}. The
robustness of the simulated degradation products is a limitation in the
approach and requires additional work but a pragmatic one given the
absence of data to refine and improve the model further.

Using a scheme aligned to the OECD categories, substances were first
assigned into one of 9 broad categories. These were refined by a
surrogate for chain length to subset each of the substances into
secondary categories such that a substance would be tagged by a primary
category e.g.~PFAAs and then a tag to denote greater/less than a carbon
chain length of 7. The threshold of 7 was a pragmatic one to help
identify long chains though the limitation was this was best suited for
straight chain linear PFAS. For each of the secondary categories, a
centroid was identified nominally expected to be representative of the
overall category. Pairwise distances relative to the centroid were
computed as a means of being able to rank order the similarity of
category members as potential candidates for additional testing. Since
in many cases, secondary categories were large and structurally diverse,
an approach was developed to derive an objective threshold to determine
if and when subcategorization using hierarchical clustering was needed
to maximize structural similarity within a category. A threshold based
on the 5th percentile of `between category' distances was devised and
applied as a stopping threshold. Ultimately a set of 85 terminal
categories were proposed which could be prioritized based on those
categories containing TSCA substances as well as considerations such as
the sparsity of relevant toxicity and environmental data.

These 85 proposed terminal categories are limited in that they are
structural in nature and anchored by the expectation that structural
similar substances are likely to exhibit similar properties. Per current
read-across technical guidance, structural similarity is only one
component of a read-across assessment and many other considerations come
into play. Given the sparsity of toxicity data for the PFAS landscape,
this effort was very much a pragmatic starting point to prioritize PFAS
into categories to that could help characterize the structural diversity
relative to the toxicity space. Qualitative flags from NAM testing
provided an additional component to help explore consistency of
mechanistic data within a terminal category or help inform relevant
higher tier data though it is recognised that only 124 substances had
been tested across the NAM assays and which had passed QC. The NAM flags
have limited utility in highlighting potential tiered testing for a
candidate substance, the NAM profile of the neighboring substance could
provide some indications of which tiered testing might be more
informative depending on category or what to expect as far as TK
considerations0. The NAM data also could be evaluated in concert with
existing \emph{in vivo} potency data where available to help rationalize
the variability of the data. Publicly available \emph{in vivo} data
across the terminal categories was used to evaluate whether read-across
could be potentially viable based on the variation of the \emph{in vivo}
data itself. A 10th percentile of the minimum POD values for a given
substance was calculated to derive a single value per substance. Not all
terminal categories were associated with toxicity data but for those
categories, the following insights were noted; substances with lower
carbon chain length within a category tended to exhibit lower toxicities
(i.e., higher PODs), but the spread of PODs within a category could be
large particularly for diverse categories based on carbon chain length,
spanning 2 orders of magnitude or more. In addition to the shift in
potency between terminal categories containing longer vs short chain
lengths, there was also a shift between terminal categories with
different functional groups e.g.~Non-PFAA perfluoroalkyls tended to be
less potent vs.~PFAAs.

Evaluations of physical chemical similarity were also performed to
explore the extent to which profiles were consistent across terminal
categories.

Beyond a centroid as the nominal representative candidate substance
characterizing the category, MaxMin approaches were applied to identify
additional substances that could help bound the domain of the terminal
category as a whole or when constrained by membership of TSCA substances
or TSCA active substances only. A measure of \%structural diversity
coverage relative to the number of MaxMin substances selected was
determined for both the unconstrained and TSCA active space -- if 80\%
of the structural diversity needed to be captured from the full
landscape across all 85 terminal categories, then over 5000 substances
would need to be selected for further evaluation which would be
practically challenging, whereas across the TSCA active landscape, a
more manageable 115 substances would address a 80\% structural diversity
threshold. This highlights the initial pragmatic choice of setting a
fixed number of MaxMin substances to be drawn from each terminal
category would benefit from refinement to select different number of
substances depending on the size of terminal category.

Refinements are expected to adjust the terminal categories based on the
data generated through additional NAM testing or through the
conventional data accessed. This workflow of devising structural
categories shows promise as a practical and pragmatic means to help
inform subsequent prioritization of candidates for additional tiered
testing.

\hypertarget{references}{%
\section*{References}\label{references}}
\addcontentsline{toc}{section}{References}

\renewcommand{\bibsection}{}
\bibliography{PFAS.bib}

\newpage{}

\newpage
\appendix
\renewcommand{\thefigure}{A\arabic{figure}}
\renewcommand{\thetable}{A\arabic{table}}
\setcounter{figure}{0}
\setcounter{table}{0}

\hypertarget{supplementary-information}{%
\section{Supplementary information}\label{supplementary-information}}

\hypertarget{sec-supp}{%
\subsection{Evaluating the feasibility of subdividing the primary
categories}\label{sec-supp}}

Corina Symphony on the command line (licensed from Molecular Networks
GmBH and Altamira LLC) was used to compute the 129 PFAS ToxPrints
\citep{richard_new_2023}. The Fisher's exact test was used to compute an
odds ratio and associated p value for each PFAS ToxPrint relative to the
OECD primary category designation. This was comparable with the
methodology discussed in Wang et al. \citep{wang_high-throughput_2019}.
A PFAS ToxPrint was considered enriched if it had an odds ratio greater
than or equal to 3, a one-sided Fishers exact p-value less than 0.05
(probability value of the odds ratio being greater than 1) and the
number of True Positives (TP) was determined to be greater than or equal
to 3. For the ``Unclassified'' primary category, the top 2 enriched
ToxPrints were PFAS chain features: FT\_n3\_N, FT\_n1\_OP both of which
represent fluorotelomer chains with either 3 or 1 CH2 units and a
nitrogen or organophosphorus terminus. On the otherhand, the ``Other
aliphatics'' had heteroatoms, nitrile and primary amines as enriched
functional groups. The intention was to explore whether certain types of
features were specifically enriched in these broad primary categories to
consider splitting them apart to reduce the starting membership. The
full set of enrichments for all primary categories are provided as a
separate data file.

\newpage{}

\hypertarget{supplementary-figures}{%
\section*{Supplementary Figures}\label{supplementary-figures}}
\addcontentsline{toc}{section}{Supplementary Figures}

\begin{figure}

{\centering \includegraphics{FigureS1_miti_200823.png}

}

\caption{\label{fig-miti}Overlap of MITI training data substances with
TSCA substances using Morgan chemical fingers and represented in a t-SNE
plot}

\end{figure}

\begin{figure}

{\centering \includegraphics{FigureS1_withinECDF_200823.png}

}

\caption{\label{fig-ecdfs-within}ECDFs of the within categories based on
the chain length threshold of 7}

\end{figure}

\newpage{}

\begin{figure}

{\centering \includegraphics{FigureS3_betweenECDF_220823.png}

}

\caption{\label{fig-ecdfs-bet}EDCFs for selected between category
combinations for carbon chain length categories}

\end{figure}

\begin{figure}

{\centering \includegraphics{FigureS4_shiftECDF_100423.png}

}

\caption{\label{fig-ecdfs-left}EDCFs for selected terminal categories to
demonstrate left shift in pairwise distance}

\end{figure}

\begin{figure}

{\centering \includegraphics{FigureS6_corr_memsize_220823.png}

}

\caption{\label{fig-cat-mem}Correlation between terminal categories with
large membership size and the number of testing tracks represented
amongst their memberships}

\end{figure}

\begin{figure}

{\centering \includegraphics{FigureS7_HM_NAM_flags_cats_220823.png}

}

\caption{\label{fig-nams-hm}Heatmap of NAM flags for substances tested
that overlap with the PFAS inventory}

\end{figure}




\end{document}
